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AuSPEN Welcome
2017 Organising Committee
Welcome to the AuSPEN 2017 Conference!
On behalf of the AuSPEN Council, Scientific 
Committee and the Local Organising Committee, it 
is our pleasure to welcome you to the 43rd Annual 
Scientific Conference of the Australasian Society for 
Parenteral and Enteral Nutrition (AuSPEN) on the 
Gold Coast. 
We hope that this year’s conference theme of 
“Collaboration in Clinical Nutrition – Evidence 
Based Nutrition for Improving Patient 
Outcomes” provides you with the latest evidence, 
inspiration and practical tips for best clinical nutrition 
patient outcomes.  We are thrilled to welcome 
Professors Stansialw Klek and Remy Meir as our 
keynote international speakers providing a wealth 
of clinical nutrition experience and insights. We 
are also honoured to welcome Dr Bhuvaneshwari 
Shankar from India,  who will enlighten us to cultural 
considerations in providing nutrition support. Via 
video link we will also be updated and inspired 
by leading international clinical nutrition experts 
Professors Alessandro Laviano, Isabel Correia and 
Dan Waiztberg.
The conference program features concurrent 
workshops on Thursday 16th November including the 
very popular ESPEN LLL courses: Nutrition Support 
in Gastrointestinal Diseases, and Nutrition Support in 
Cancer. We have again included a paediatrics clinical 
nutrition workshop after the success of last year’s 
workshop in Melbourne. For the first time we are 
conducting a Knowledge Translation workshop, to 
provide the “know how” and show case exemplars in 
implementation science to inspire you to continually 
improve your clinical nutrition practice. 
The main program on Friday and Saturday will 
feature plenary sessions and symposia on a wide 
range of nutrition support and clinical nutrition 
topics (including enteral and parenteral nutrition in 
overweight and obesity, enhanced recovery after 
surgery, nutrition in oncology, cultural considerations 
in nutrition support, gastroenterology and 
microbiota, panel discussions with case-studies on 
collaboration, and more!) and of course the AuSPEN 
free paper oral presentations and poster display. 
We hope that you can enjoy your time on the 
beautiful Gold Coast and have a chance to explore 
the hinterland and relax on the beautiful beaches. 
A big thank you to our AuSPEN members, speakers, 
poster presenters, industry partners and sponsors, 
organizing committee and of course our attendees. 
Please make the most of this time to network with 
leaders in the clinical nutrition field, share your 
challenges and wins and work together as we make 
the 43rd Annual AuSPEN Scientific Conference on the 
Gold Coast one to remember. 
Ibolya Nyulasi           Liz Isenring
AuSPEN President        Chair, Scientific Committee 
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Prof. Isabel Correia - Brazil (via videolink)
Prof. Correia is a Professor of Surgery at the Universidade Federal de Minas 
Gerais and Chief of the Nutrition Therapy Team at the Alfa Institute of 
Gastroenterology and Surgery of the University Hospital, Belo Horizonte, 
Brazil. Her research includes the nutritional needs of patients with cancer and 
undergoing liver transplant. Prof. Correia will join us at AuSPEN via videolink to 
present in the main program
Prof. Stanislaw Klek - Poland 
Prof. Klek is a Surgical Oncologist.  He is the Chairman of the Polish Society 
for Parenteral, Enteral Nutrition & Metabolism (POLSPEN) and the Chair-Elect 
of the International Section of ASPEN. Prof. Klek is also an associate editor 
of Clinical Nutrition and head of the Oncological Surgery Unit and HPN unit at 
Stanley Dudrick’s Memorial Hospital in Skawina, Poland. His research interests 
include clinical nutrition, metabolism, surgery, oncology and ultrasonography. 
As an accredited ESPEN LLL teacher, he will contribute to teaching the AuSPEN 
LLL sessions, as well as present in the main program. 
Prof. Alessandro Laviano - Italy (via videolink)
Prof. Alessandro Laviano is Associate Professor of Internal Medicine at the 
Department of Clinical Medicine, Sapienza University of Rome, Italy. He works 
at the Clinical Nutrition Unit of the Sapienza University Hospital in Rome, Italy. 
Also, Prof. Laviano holds a position of Visiting Research Professor at Upstate 
Medical University, Syracuse, NY, USA. Prof. Laviano received his MD degree at 
the Sapienza University of Rome, Italy, where he also completed the residency 
programmes in Internal Medicine and Nephrology. Prof. Laviano will join us at 
AuSPEN via videolink to present in the main program
Prof. Remy Meier - Switzerland
Prof. Meir is a Gastroenterologist and Professor at the University of Basel, 
and recognised as a specialist in clinical nutrition.  He was chairman of the 
Education Committee of ESPEN and is now the co-director of the ESPEN LLL 
Program. He will facilitate the ESPEN LLL sessions as well as present in a 
plenary session in the main program. 
Dr. Bhuvaneshwari Shankar - India
Dr. Bhuvaneshwari Shankar is the Vice President (Dietetics) and Group Chief 
Dietitian for the Apollo Hospitals Group. She has 32 years of Experience 
as a Dietitian. Dr. Bhuvaneshwari holds a PhD in Clinical Nutrition, with 
a specialisation in Critical Care Nutrition. She is an Examiner for various 
Universities, member, Board of Studies - Nutrition, Madras University and has 
received a Lifetime Achievement Award from the JBAS College, Chennai. She is 
an Expert Committee Member, Nutrition Board- Government of India. 
Dr. Shankar will present in the main program.
Prof. Dan Waitzberg - Brazil (via videolink)
Prof. Waitzberg is a Gastrointestinal Surgeon, Director of Laboratory of 
Investigation in Metabolism and Nutrition in Digestive Surgery at FMUSP, 
and Clinical Director of Nutrition Services University of Sao Paulo Medical 
School. His main area of research is clinical nutrition, with special interest 
in inflammatory response, malnutrition, immunonutrition and enteral and 
parenteral nutrition in the context of surgery and cancer. Prof. Waitzberg will 
give a number of presentations in the main program.
Louise Becroft
Louise Becroft is a senior dietitian 
working in the upper gastro-
intestinal surgery unit at the 
Alfred Hospital, Melbourne.  She 
specialises in bariatric surgery.  
She has had extensive experience 
working as a clinical dietitian in both Australia and 
the UK.  Louise is active in research in bariatric 
nutrition, currently undertaking further post 
graduate studies in body composition changes and 
outcomes in the morbidly obese population.
Kristie Bell
Dr. Kristie Bell is a paediatric 
dietitian with over 18 years 
of clinical paediatric dietetics 
experience. She is the Dietitian 
Consultant at Lady Cilento 
Children's Hospital, Brisbane and is a Senior 
Research Fellow with the University of QLD.  Dr. Bell 
has a special interest in the nutritional management 
of children with physical disabilities and completed 
her PhD in this area. Current research interests 
include development and validation of a screening 
tool for feeding and nutrition disorders in children 
with cerebral palsy.
Katie Benton
Katie Benton has worked in 
cancer care for seven years. 
This has included head and 
neck cancer, haematology and 
surgical UGI oncology. With a very 
keen interest in research, Katie 
has been data manager for two NHMRC cancer 
trials and recently submitted her manuscript on 
nutritional management of patients undergoing 
an enhanced recovery after surgery protocol 
post oesophagectomy. Katie is passionate about 
improving the health and wellbeing of people living 
with cancer.
Katrina Campbell
Katrina Campbell is an Advanced 
Accredited Practising Dietitian and 
Associate Professor within the 
Nutrition and Dietetics program 
at Bond University. Her research 
areas of expertise include clinical nutrition, 
particularly investigating the effectiveness of 
lifestyle interventions targeting cardiovascular and 
chronic kidney disease (CKD), metabolism, drivers 
of nutritional status and the microbiome. 
Ra’eesa Doola
Ra’eesa has practiced as a clinical 
dietitian since her graduation 
from the Queensland University 
of Technology in 2005. She has 
gained a broad range of experience 
in clinical dietetics having worked 
across most acute areas in the hospital setting. 
Ra’eesa has a special interest in ‘nutrition support’ 
and is currently undertaking her PhD investigating 
the role specialised nutritional products may have in 
improving blood sugar levels in the critically ill and 
patients after surgery.
Annabel Doolan
Annabel Doolan nourishes little 
hearts at The Lady Cilento 
Children’s Hospital in Brisbane 
and is the recognised specialist 
cardiac dietitian across Queensland. 
She has extensive experience in critical care and 
nutrition support including infant tube weaning 
practices. 
Megan Farquhar
Megan is a paediatric dietitian at 
Lady Cilento Children’s Hospital 
and has specialised in the area of 
child and adolescent mental health 
for the past three years.  Megan 
has been instrumental in the 
development and implementation of a new rapid 
refeeding protocol and has developed Statewide 
guidelines for the nutrition management of 
paediatric patients with anorexia nervosa. 
Suzie Ferrie
Since 2001, Dr. Suzie Ferrie has 
been the Critical Care Dietitian in 
the ICU at Sydney’s Royal Prince 
Alfred Hospital. She is also a clinical 
affiliate lecturer at the University 
of Sydney. Author of over 30 peer-reviewed 
journal papers and a number of book chapters and 
consumer nutrition articles, her research interests 
include gut function in critical illness, and methods 
for nutritional assessment and monitoring in the 
ICU.
Invited Speakers                            
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Marcelee Gellatly 
A Speech Pathologist with extensive 
clinical skills in both adult and 
paediatric caseloads across educational, 
community health, tertiary hospital 
and private settings since graduating 
from the University of Queensland. Her 
interests include paediatric feeding and dysphagia across 
the developmental continuum and multidisciplinary 
approaches to feeding difficulties, and is passionate about 
mentoring speech pathologists in this area. Marcelee 
has specialised in the area of paediatric cardiology since 
2006 and has been a co-author on paediatric cardiology 
research publications. 
 Lyndal Gray
Lyndal Gray is the Senior Leisure 
Therapist in Cancer Services, Princess 
Alexandra Hospital, Brisbane.  Lyndal’s 
specific interest areas include using 
leisure to increase quality of life 
during cancer treatment particularly 
with adolescents and young adults. Lyndal has been a 
Communication Skills Trainer for the past 9 years and 
her wish is for all professionals working in cancer care to 
have access to appropriate and regular communication 
training to build a workforce that successfully recognizes, 
elicits and manages the psychosocial distress of cancer 
patients
Ingrid Hickman
Dr. Ingrid Hickman is an Advanced 
Accredited Practicing Dietitian and 
a Principal Research Fellow with the 
Department of Nutrition and Dietetics 
at the Princess Alexandra Hospital 
and a Senior Research Fellow with the 
Mater Research Institute-UQ, Queensland. Over the last 
15 years, her research career has focused on translating 
research findings associated with optimising metabolic 
health for people with obesity-related chronic disease.
But it has been the more recent dedication to research 
training and capacity building in clinical staff that has had 
the greatest impact on research translation in health care 
settings. 
Gerald Holtmann
Prof. Gerald Holtmann currently is 
the Director of Gastroenterology & 
Hepatology at the Princess Alexandra 
Hospital. He is an accomplished and 
internationally renowned Academic 
Gastroenterologist, with particular 
research focus in the field of neurogastroenterology and 
has led pathophysiology research in the field of functional 
gastrointestinal disorders for nearly two decades. He is 
also the Associate Dean Clinical across the two health 
faculties at the University of Queensland.
Bethany Hooke
Bethany has worked in public health 
services since 1996 as a Speech 
Pathologist, service team leader, and 
project lead in both metropolitan 
Brisbane and regional Queensland. She 
is particularly interested in how health 
services link across sectors and along the continuum 
of care to improve the experiences and outcomes 
of children and their families with additional health 
care needs. Her current position is as the CHQ NDIS 
Transition Manager.
Liz Isenring
Prof. Liz Isenring joined Bond 
University in 2014 to head up the new 
Nutrition and Dietetics programs. She 
is a leading nutrition and dietetics 
academic, an Advanced Accredited 
Practising Dietitian and previously worked at the 
University of Queensland, Flinders University and 
Queensland University of Technology. Professor Isenring 
is internationally recognised in the areas of oncology 
nutrition, nutrition in older adults, nutrition screening 
and assessment.
Jaimon Kelly
Jaimon Kelly is an Accredited Practicing 
Dietitian and PhD Scholar at Bond 
University.  Jaimon is passionate about 
improving patient-centred care in 
chronic kidney disease, is an advocate 
for patient-engagement in both the clinical and research 
setting, and has a strong interest in exploring new ways 
to deliver dietary education to improve patient's self-
management.
Andrea Marshall 
Andrea Marshall is a Professor of Acute 
and Complex Care Nursing at Griffith 
University and Gold Coast Health. 
Her program of research focuses on 
improving nutrition intake of acute and 
critically ill patients, using knowledge 
translation and implementation science as a primary 
methodology. 
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Anthony Meade
Anthony Meade is Principal Renal 
Dietitian at Central Northern Adelaide 
Renal and Transplantation Service, Royal 
Adelaide Hospital, and convenor of the 
Renal Nutrition Program. He is committed 
to taking the confusion out of renal 
nutrition practice and educating clinicians and people with 
chronic kidney disease on the practical aspects of renal 
nutrition.
 Mark Morrison
Prof. Mark Morrison joined the 
University of Queensland Diamantina 
Institute in October 2013, as chair 
and principal group leader in microbial 
biology and metagenomics. Mark 
serves as Australia’s science representative to the 
International Human Microbiome Consortium and 
holds an affiliate Professorship with the University 
of Queensland’s School of Chemistry and Molecular 
Biosciences.
Jane Nearhos
Jane Nearhos is a Psychologist with 
over 20 years experience in disability, 
rehabilitation, mental health, and 
health care. She has also worked 
with diabetes care and chronic pain management. Her 
current role is with the multidisciplinary team providing 
training and support to home haemodialysis users at 
Princess Alexandra Hospital in Brisbane. Her research 
interests are in the psychological adjustment of people 
with chronic illness, particularly kidney disease.
Harald Puhalla
A/Prof. Harald Puhalla is a bariatric 
surgeon with private and public 
appointments at the Gold Coast. 
He teaches surgery at the Griffith 
University and has published more than 
30 scientific articles.
Shelley Roberts
Dr. Shelley Roberts is a dietitian 
and a postdoctoral research fellow 
at Griffith University. Her research 
focuses on improving nutrition among 
hospitalised patients, with particular 
interests in patient engagement, 
healthcare technologies, and integrated knowledge 
translation.
Shannon Springer
Dr. Shannon Springer is the Associate 
Professor and the Discipline lead 
for Aboriginal and Torres Strait 
Islander Health at Bond University 
on the Gold Coast. Shannon is a GP 
and a Fellow of Royal Australian College of General 
Practitioners, and practice owner with a passion for 
Indigenous Primary Health Care, Medical Education 
and Community Development. He sits on the board 
of the Australian Indigenous Doctors Association and 
the Royal Australian College of General Practitioners 
National Faculty for Aboriginal and Torres Strait 
Islander Health. 
Iain Thomson
Dr. Iain Thomson is a consultant 
surgeon with the upper 
gastrointestinal unit at the Princess 
Alexandra Hospital and senior 
lecturer with the University of 
Queensland.  He has an interest in ongoing surgical 
research in particular applying this to oesophageal 
and gastric cancer.  This interest has seen the PAH 
UGI unit recently changed to a enhanced recovery 
program for oesophagectomy patients. 
Elizabeth Upton
Elizabeth Upton has fourteen years 
of experience as a clinical pharmacist 
working in various hospitals and in 
various roles across Australia and the 
United Kingdom.  Elizabeth is now 
happily part of the Women’s and Families team at the 
Sunshine Coast University Hospital.  Elizabeth’s main 
area of interest is neonatal care.
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Barbara van der Meij
Dr. Barbara van der Meij is a conjoint 
senior research dietitian at Bond 
University and Mater Group, mainly 
focusing on nutrition and muscle 
wasting in cancer and older adults, 
focusing on efficacy of nutritional 
support strategies such as omega-3 fatty acids, 
essential amino acids and meal adaptations. Her 
ultimate goal is to improve quality of life and outcomes 
in cancer patients and older adults.
Shelley Wilkinson
Dr. Shelley Wilkinson is an Advanced 
Accredited Practising Dietitian and 
the Senior Research Dietitian in the 
Mater Mothers’ Hospital, Brisbane. She 
currently holds a Queensland Health - 
Health Research Fellowship and has previously held an 
NHMRC TRIP Fellowship. Shelley has been a dietitian 
since 1995 and also has a PhD in Psychology.
INSTAGRAM:
#AuSPEN2017
FACEBOOK:
www.facebook.com/
AuSPENConf
Boutaina Zemrani
Dr. Boutaina Zemrani is a fellow 
in Clinical Nutrition and Intestinal 
Rehabilitation at the Royal 
Children’s Hospital in Melbourne. 
After completing general pediatric 
training in several countries 
including Switzerland, Morocco and Belgium, she 
obtained a European Inter-University Degree in 
Clinical Nutrition and Metabolism (Artificial Nutrition) 
at the University of Paris Descartes in Paris France. 
Boutaina is passionate about improving the nutrition 
and well-being of paediatric patients.
TWITTER:
@AuSPENConf
Social Media   
Like, Tweet and Follow us throughout the conference here:
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Past AuSPEN Conferences               
This is the 43rd AuSPEN Annual Scientific Meeting, 
one of the longest running PEN societies in the world!
Travelling all over Australia and New Zealand the last 
10 years:
• 2006 Sydney
• 2007 Perth
• 2008 Sydney  
• 2009 Christchurch
• 2010 Gold Coast
• 2011 Melbourne
• 2012 Adelaide    
• 2013 Sydney 
• 2014  Auckland 
• 2015  Brisbane                                                                      
• 2017 Gold Coast
     
Future conferences:                            
Further information about the 2018 conference will 
be posted on the AuSPEN website in December 2017. 
www.auspen.org.au
AuSPEN Research Grants                                     
AuSPEN has a rich history in funding of research.  In 
2017 AuSPEN has again offered a generous amount of 
grant funding to members.  
Annual General Meeting                
Friday 18th November 5.30-6.15pm
•Attendance is for financial members only (includes 
any new members whose approval has been 
processed)
•Sign in of attendance is mandatory
Have you enjoyed the AuSPEN ASM?
Then join up as an AuSPEN member now!
The Australasian Society for Parenteral and Enteral 
Nutrition is Australasia’s only multi-disciplinary 
society representing health professionals in the field 
of Clinical Nutrition. AuSPEN membership offers 
many member benefits, not least opportunity to 
network with colleagues throughout Australia and 
New Zealand. If you are not yet a member but have 
enjoyed all our Annual Scientific Meeting has offered, 
please consider joining our Society.
AuSPEN INFORMATION
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Applying to Join AuSPEN                           
By joining now, you will be eligible for a part-year 
membership fee of only $185.* Visit www.auspen.org.
au and follow Apply for Membership. Joining requires a 
credit card payment and takes only 2 minutes. Member 
benefits commence immediately.
AuSPEN looks forward to your membership and your 
contributions! *the AuSPEN membership runs from 
1 July each year until 30th June the following year ( 
current full year fee is $225).
Conference Etiquette:         
Please ensure that your mobile phone and other 
electronic devices are switched off or onto silent during 
conference sessions. As a courtesy to the speakers and 
your fellow delegates, we also request that you limit 
use of phones, laptops or tablets during the sessions to 
taking notes on the speaker presentations. If you have 
other work and correspondence that urgently requires 
attention, please leave the session room and attend 
to this outside.  Photography or videorecording using 
any device (camera, smartphone or tablet) during the 
conference sessions is NOT PERMITTED except with 
prior approval by AuSPEN. Delegates not adhering to 
this requirement may be asked to leave the conference 
session.
 
Name Badges          
Your name badge allows entrance to all sessions. You 
must wear this badge at all times whilst within the 
venue. Should you lose your badge, please visit the 
registration desk for a replacement.
Dietary Requirements           
If you have a special dietary requirement and you 
did not notify Corporate Communique (congress 
managers), please visit the registration desk to see if 
your request can be arranged. Please note that request 
for Nonspecific requirements, such as low GI and low 
fat cannot be guaranteed.
AuSPEN2017
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Getting around the conference centre...
Concurrent Session 1(a) - 0830-1230
  
Thursday 16th November
ESPEN LLL: Nutrition Support in GI Diseases
Chair: Susannah King
Facilitators: Prof. Remy Meier, Prof. Stanislaw Klek
Marquis Room
Times 
0830-1015
Topic Speaker
The Compromised Gut Prof. Stanislaw Klek
Challenges in treating intestinal failure in short bowel Prof. Stanislaw Klek
Nutritional support in gastrointestinal fistulas Prof. Remy Meier
10.15-1045 Morning tea
Times
1045-1230
Topic Speaker
Nutritional support in inflammatory bowel diseases Prof. Remy Meier
Case-studies 
LLL Test
Case-studies and LLL Test
1230-1330 Lunch
Concurrent Session 1(b) - 0830-1230
  
Workshop: Implementing best evidence into practice – how and why
Chair: Prof. Andrea Marshall
Speakers / Facilitators: Prof. Andrea Marshall, Dr. Shelley Wilkinson, Dr. Shelley Roberts, Dr. Ingrid Hickman 
Monarch Room
If you’ve ever wondered how you put into practice the evidence gained from journal papers-this workshop is for you!
In this Implementation Science Workshop the fundamental concepts of knowledge translation and implementation will be explored 
as they relate to the delivery of effective, efficient, safe and timely patient centred care. Leading knowledge translation and 
implementation clinician researchers will discuss their experiences of preparing the workforce for knowledge translation; using 
integrated knowledge translation to ensure clinicians, consumers and researchers develop and implement meaningful strategies 
to improve practice; developing complex interventions; and, developing sustainable interventions. Each speaker will use exemplars 
from their work which illustrate how knowledge translation principles and research can shape and improve nutrition care.
Times Topic Speaker
0830-0845 Introduction & aims of the workshop Prof. Andrea Marshall
0845-0915 What is knowledge translation( KT) and implementation science? Prof. Andrea Marshall
0915-0945 KT Exemplar 1: Preparing a workforce for KT Dr. Ingrid Hickman
0945-1015 KT Exemplar 2: Partnering with consumers to implement change in clinical nutrition 
practice 
Prof. Andrea Marshall
10.15-1045 Morning tea
1045-1115 KT Exemplar 3: Using technology to engage patients in their nutrition care Dr. Shelley Roberts
1115-1145 KT Exemplar 4: 
Sustainable statewide dietetic model of care implementation in GDM
Dr. Shelley Wilkinson
1145-1230 Where to from here: Panel discussion dealing with problems and resources Facilitator: 
Prof. Andrea Marshall
1230-1330 Lunch
PRE-CONFERENCE EDUCATIONAL EVENTS
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Thursday 16th November
Concurrent Session 2(b) - 1330-1730
Paediatric Workshop – Translating evidence into practice
Chair: Julia Fox
Monarch Room
Are you working in the field of paediatrics or just interested in expanding your knowledge base? Then the paediatric workshop, 
translating evidence into practice, is for you! 
We have a broad range of speakers from a variety of disciplines and backgrounds who work in the clinical and research setting. 
They will help guide you through the sometimes difficult path of applying the most recent evidence based outcomes into prac-
tice in the clinical setting. Speakers include Dr. Kristie Bell who has many years of experience in applying her own research into 
clinical practice and is  highly regarded in the world of cerebral palsy nutrition. We will also hear from Bethany Hook, who in 
her current role as NDIS transition manager, is working to help health professionals and families prepare for the NDIS. Her pre-
sentation will explore what health professionals can do to help support NDIS readiness.  We also have speakers from Speech 
Therapy, Dietetics, Pharmacy and Medicine allowing for a true multi professional workshop. We will conclude the session with 
a networking meeting for health professionals working or interested in the area of parenteral nutrition and intestinal failure.
Times
1330-1515
Topic Speaker
1330-1415 Nutrition support for paediatric cardiac conditions and tube weaning 
programs
Annabel Doolan & 
Marcelee Gellatly
1415-1445 Rapid refeeding protocols for children and adolescents with eating disorders Megan Farquhar
1445-1515 NDIS in paediatrics – how will it work? Bethany Hooke
1515-1545 Afternoon tea
1545-1610 Monitoring of long term parenteral nutrition Dr. Boutania Zemrani
1610-1635 What is the evidence for probiotic use in neonates and children Elizabeth Upton
1635-1700 Optimising growth for children with cerebral palsy- Red flag study Dr. Kristie Bell
1705-1730 Parenteral Nutrition Interest Group Meeting Dr. Shelley Wilkinson
Concurrent Session 2(a) - 1330-1730
ESPEN LLL: Nutrition Support in Cancer
Chair: Azmat Ali
Marquis Room
Times
1330-1515
Topic Speaker
Mechanisms and clinical features of cancer cachexia Prof. Stanislaw Klek
Nutritional effects of cancer therapy and potential modulation of tumor growth Dr. Barbara van der Meij
Multimodal therapy for cancer cachexia Prof. Remy Meier
1515-1545 Afternoon tea
Times
1545-1730
Topic Speaker
Pharmacologic Therapy Prof. Remy Meier
Case-studies
LLL Test
PRE-CONFERENCE EDUCATIONAL EVENTS
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Friday  17th November
0830-0840   Welcome and conference opening.  Prof. Ibolya Nyulasi, President of AuSPEN
Times Topic Speaker
0840-1010  Opening symposium: Collaboration in Clinical Nutrition - Oncology
Chairs: Prof. Liz Isenring and  Prof. Ibolya Nyulasi - Marquis Room
0840-0915 Optimal Nutritional care during cancer treatment (via videolink) Prof. Alessandro Laviano
0915-0950 Is Nutrition still important in the new era of surgical oncology? Prof. Stanislaw Klek
0950-1010 Models of care in cancer nutrition: how do we translate ESPEN guidelines into practice? Dr. Barbara van der Meij & 
Prof. Liz Isenring
1010-1045 Morning tea & poster viewing
Concurrent Abstract Sessions
1045-1230   Oral presentations selected from abstract submissions
Monarch                                       Chairs: Dr. Varsha Astrani and Prof. Liz Isenring Presenting author
1045-1100 The effect of resveratrol on cognitive performance: a systematic literature review and 
meta-analysis
Wolfgang Marx
1100-1115 Malnutrition Prevalence and Associated Outcomes Lauren Grundy
1115-1130 Measured energy expenditure in critically ill burn patients correlates with time post-injury but 
not burn size
Susannah King
1130-1145 Effects of substitution or addition of carbohydrate and fat to protein supplements on gastric 
emptying, gut hormones and energy intake in healthy older men
Stijn Soenen
1145-1200 Appetite and nutrient intake in survivors of critical illness Lee-anne Chapple
1200-1215 An audit of the postoperative nutritional practices following major abdominal surgery Jessie Varghese
1215-1230 Assessing treatment options for intestinal failure patients using time trade-off methodology. Sharon Carey
Marquis                                       Chairs: Dr. Skye Marshall and Dr. Barbara van der Meij Presenting author
1045-1100 Pre-operative malnutrition is a predictor of post-operative outcomes in Peritonectomy Surgery Lauren Reece
1100-1115 Platinum-induced fatty acids are present in cancer patients but may not be associated with treat-
ment response
Laisa Teleni
1115-1130 Depressed mood and cognitive functions in patients with cancer are associated with alterations 
in tryptophan metabolism
Dr. Barbara van der Meij
1130-1145 Sarcopenia is associated with sedentary behaviour and physical activity in people with malignant 
pleural mesothelioma
Emily Jeffery
1145-1200 Enteral nutrition support and treatment toxicities in patients with head and neck cancer receiv-
ing helical intensity-modulated radiotherapy with concurrent chemotherapy
Claire Blake
1200-1215 Tolerability of early enteral nutrition post allogeneic stem cell transplantation - a randomised 
comparison to standard care
Sarah Andersen
1215-1230 Improving nutrition cancer care outcomes - findings from a state-wide benchmarking pilot study Natalie Simmance
1230-1400 Lunch & poster viewing
1400-1540   Symposium 2: Microbiota in managing chronic disease.  Chairs: Dr. Rebecca Burgell and Alan Spencer     
1400-1435 Microbiota and probiotics in inflammatory bowel disease Prof. Remy Meier
1435-1500 Looking from the outside into the functional gut disorder microbiome Prof. Mark Morrison 
1500-1525 Gut mucosa and microbiome: Part of the puzzle of functional gastrointestinal disorders? Dr. Gerald Holtmann
1525-1540 Pre, Pro and Synbiotics in chronic kidney disease A/Prof. Katrina Campbell
1540-1610 Afternoon tea & poster viewing
1610-1730   Symposium 3: Nutrition support in kidney disease.  Chairs: Dr. Sharon Carey and Hannah Mackay                                              
1610-1650 Philosophies around nutrition support in kidney disease: a focus on IDPN Anthony Meade
1650-1710 Delivering telehealth for management of CKD: Clinical outcomes versus patient experience Jaimon Kelly
1710-1730 Psychological factors that act on dietary compliance in patients with kidney disease Jane Nearhos
1730-1815 AUSPEN Annual General Meeting (held in the Marquis room) Ibolya Nyulasi  
1815-2100 Welcome Cocktail Party: Pina Colada Tropicana.....  
Poolside Deck, Royal Pines Resort. 
Dress code: Smart Casual-Tropical
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Saturday  18th November
0700-0815   Fresenius Breakfast Meeting - registration required for this. (Convention Lobby, Royal Pines Resort)
0830-1010  Symposium 4: Collaborating for nutrition support Pre & Post-surgery 
                      Chairs: Sophie Lane and Ra'eesa Doola  
Time Topic Speaker
0830-0850 Complexity of malnutrition in surgical patients (via videolink) Prof. Isabel Correia
0850-0910 Feeding route options for supporting surgical patients Prof. Stanislaw Klek
0910-0930 Implementation of ERAS - a surgeon’s perspective Dr. Iain Thompson 
0930-0945 Implementation of ERAS in upper GI patients – treading new ground for implementation Katie Benton  
0945-1000 A new Model of Care in Gynaeoncology patients – the pragmatics of implementing and sus-
taining an ERAS MOC.
Ra’eesa Doola 
1000-1010 Speaker Q&A
1000-1040   Morning tea & poster viewing
1040-1200  Symposium 5: Nutrition Support in Obesity    
                     Chairs: Alice Murray and Todd Leeder                         
1040-1100 Biomolecular approach to consequences of bariatric surgery (via videolink) Prof. Dan Waitzberg
1100-1220 Post-operative bariatric surgery – what to do when it goes wrong Dr. Harald Puhalla
1120-1140 Nutritional requirements for the obese patient in ICU and complex situations Dr. Suzie Ferrie
1140-1200 Nutritional requirements of the obese patient, how to escalate and advocate for appropriate 
care within the MDT
Louise Becroft
1200-1300   Lunch & poster viewing
1300-1430   Symposium 6: Cultural Considerations, collaboration and communication in nutrition care 
                      Chairs: Siong Pang and Dr. Stijn Soenen
1300-1345 What is culturally appropriate health care? Dr. Shannon Springer
1345-1410 Multidisciplinary patient engagement for better outcomes Lyndal Gray
1410-1430 Successes & challenges for nutrition support in India Dr. Bhuvanka Shankar
1430-1500   Afternoon tea & poster viewing
1500-1625   Symposium 7: Expert Panel Discussion – Hot Topics in  Nutrition Support
1500-1625   Moderator:  Russel Canavan
Panel Members: Prof. Stanislaw Klek (Surgeon), Alan Spencer (Dietitian), Ibolya Nyulasi, Lee-Anne Chapple
Nutrition Support: Navigating the conflicting evidence to move forward  - Prof. Stanislaw Klek
Showing the impact of nutrition: what are the right endpoints?  - Lee-Anne Chapple
Are Nutrition Support Teams effective in the modern Australasian clinical setting? - Panel discussion
1625-1630 Awards results announced & conference close by Prof. Ibolya Nyulasi, AuSPEN President
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Fresenius Kabi is delighted to announce a new service to 
support the supply of parenteral nutrition across Australia.
Fresenius Kabi@Home has been designed to optimally 
support the provision of home parenteral nutrition to 
facilitate the transition of patients from hospital to home.
Fresenius Kabi is a global healthcare company that 
specialises in lifesaving medicines and technologies for 
infusion, transfusion and clinical nutrition. Our products 
and services are used to help care for critically and 
chronically ill patients.
With our corporate philosophy of “caring for life”, we are 
committed to putting essential medicines and technologies 
in the hands of people who help patients and finding the 
best answers to the challenges they face.
To find out more please visit the Fresenius Kabi booth 
during AuSPEN or speak to your local Fresenius Kabi 
representative. 
Fresenius Kabi@Home 
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2017 ABSTRACTS
Abstract presentations: Oral free papers and 
posters
The AuSPEN ASM program includes presentation 
of accepted abstracts, in either poster format or 
oral free paper presentation. This year’s abstracts 
encompass a wide range of interesting projects 
across the clinical nutrition field. Delegates are 
encouraged to attend the concurrent free paper 
oral presentation session held between 10.45-
12.30pm on Friday, 17th November and to view 
the posters and ask questions / discuss results 
with the presenters.
Awards         
Eligible presentations will be evaluated by our 
AuSPEN judging panel for the two AuSPEN 
prizes:-
The Bob McMahon Prize will be preferentially 
awarded to an outstanding research presentation 
which may encompass:
• Basic science
• Clinical research
• Clinical epidemiology
• Systematic reviews are considered to be 
within the research category.
The David Russell Prize will be preferentially 
awarded to an outstanding Clinical Service 
Enhancement presentation which may 
encompass:
• Translational research / translation of 
research into practice
• Quality improvement programs/projects
• Service development projects
• Service/program analysis/evaluation
*Winners will be announced at the soical event 
on Friday the 17th November, 2017
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Poster Presentations       
The Conference posters will be available for 
viewing in the Exhibition Area on the Friday and 
Saturday during the Morning Tea, Lunch and 
Afternoon Tea breaks. Poster presenters have 
been asked to be available for questions and 
discussions near their poster the lunch break 
on Friday, 17th November and during the lunch 
break on Saturday, 18th November.
List of Abstracts        
The following pages show a list of all accepted 
abstracts in order of the first author's surname, 
their unique ID number, the page the abstract is 
shown in this program.
Disclaimer        
The abstracts of the presentations were set 
individually by the authors. Text of the abstracts 
is as provided by the authors, and AuSPEN takes 
no responsibility for errors or incorrect data 
contained within the abstracts. The opinions, 
findings, conclusions and recommendations are 
those of the individual authors.
Information for Poster Presenters  
Please ensure that your poster is mounted by 
8.15am on Friday, 17th November in the poster 
display area. Removal of posters is to be done 
by 3.00pm on Saturday, 18th November. No 
responsibility can be taken for poster left on 
display after this time.
Poster presenters should ensure that they are 
present near their poster from from 12.30-2pm 
on Friday, 17th November for the main poster 
viewing session.
 
Presenters should also make themselves 
available for questions and discussion with 
conference delegates during the lunch break on 
Saturday, 18th November.
Unique ID Title of abstract Author  Page #
345748034
IMPLEMENTATION AND EVALUATION OF SELF ADMINISTERED MALNUTRITION 
SCREENING IN GASTROENTEROLOGY OUTPATIENTS
Ms Amy Allia 20
345687906
TOLERABILITY OF EARLY ENTERAL NUTRITION POST ALLOGENEIC STEM CELL  
TRANSPLANTATION - A RANDOMISED COMPARISON TO STANDARD CARE
Ms Sarah Andersen 20
345294228 DIETITIANS AT THE POINTY END: INSERTION OF NASOGASTRIC TUBES Ms Rhonda Anderson 21
345302280 WHAT'S THE MISSING PIECE OF OUR PARENTERAL PUZZLE? Ms Emma Armstrong 21
345729541
PREVALENCE OF MALNUTRITION, NUTRITIONAL PROFILE AND LENGTH OF STAY IN 
RENAL INPATIENTS
Ms Su Bahceci 22
345729553
THE VALIDITY OF MULTI-FREQUENCY BIOELECTRIC IMPEDANCE METHODS TO 
MEASURE BODY COMPOSITION IN OBESE PATIENTS: A SYSTEMATIC REVIEW
Miss Louise Becroft 22
345724017
ENTERAL NUTRITION SUPPORT AND TREATMENT TOXICITIES IN PATIENTS WITH HEAD 
AND NECK CANCER RECEIVING HELICAL INTENSITY-MODULATED RADIOTHERAPY WITH 
CONCURRENT CHEMOTHERAPY 
Miss Claire Blake 23
345300391 ENTERAL NUTRITION - EVIDENTLY NOT! Ms Lina Breik 23
339848783
ASSESSING TREATMENT OPTIONS FOR INTESTINAL FAILURE PATIENTS USING TIME 
TRADE-OFF METHODOLOGY.
Dr. Sharon Carey 24
339849148
DEVELOPMENT OF A CONSENSUS ON MODELS OF CARE IN ADULTS WITH INTESTINAL 
FAILURE USING A MODIFIED DELPHI APPROACH. 
Dr. Sharon Carey 24
335058471 APPETITE AND NUTRIENT INTAKE IN SURVIVORS OF CRITICAL ILLNESS Dr. Lee-anne Chapple 25
337486912
DIETITIAN PRESCRIBED NUTRITIONAL SUPPLEMENTS IN THE MEDICATION CHART 
LEADS TO INCREASED ENERGY AND PROTEIN INTAKES
Ms Sally Courtice 25
345712776
DIETARY FIBRE MODIFICATION WITH OR WITHOUT ANTIBIOTICS IN THE PREVENTION 
OF DIVERTICULITIS IN ADULTS WITH DIVERTICULAR DISEASE: A SYSTEMATIC REVIEW 
AND META-ANALYSIS
Ms Megan Crichton 26
345368122
THE VALIDITY OF PATIENT-LED  SCREENING USING THE MALNUTRITION SCREENING 
TOOL (MST) IN THE CANCER CARE AMBULATORY SETTING
Miss Emilie Croisier 26
345294126
TRANSLATION OF DIETITIAN-LED GASTROSTOMY MANAGEMENT MODEL OF CARE IN 
A REGIONAL FACILITY
Ms Kara Cronin 27
345686519
EVIDENCE FOR DIETARY FIBRE MODIFICATION IN THE PREVENTION OF ACUTE, 
UNCOMPLICATED DIVERTICULITIS:A SYSTEMATIC LITERATURE REVIEW
Miss Camilla Dahl 27
343684839
A COLLABORATIVE APPROACH TO CARING FOR PATIENTS WITH JEJUNOSTOMY 
FEEDING TUBES: KNOWLEDGE, CONFIDENCE AND ATTITUDES OF NURSING STAFF 
Ms Irene Deftereos 28
345613641
ROAD TO RECOVERY: NUTRITION CARE PATHWAY FOR UPPER GASTROINTESTINAL 
SURGICAL ONCOLOGY PATIENTS 
Ms Irene Deftereos 28
345731757
CHEMOTHERAPY... THE OVERLOOKED TREATMENT IN HEAD AND NECK CANCER. A 
REVIEW OF NUTRITION OUTCOMES.
Ms Elise Den 29
345752281 NUTRITION -  A MUCH BIGGER PLAYER IN CRITICAL CARE THAN WE THOUGHT? Ms Ra'eesa Doola 29
345735810 MALNUTRITION PREVALENCE AND ASSOCIATED OUTCOMES Miss Lauren Grundy 30
345715854
SARCOPENIA IS ASSOCIATED WITH SEDENTARY BEHAVIOUR AND PHYSICAL ACTIVITY 
IN PEOPLE WITH MALIGNANT PLEURAL MESOTHELIOMA
Mis Emily Jeffery 30
345729212
THE EFFECT OF POLYPHENOLS ON CARDIOVASCULAR RISK FACTORS IN 
HAEMODIALYSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Mr Jaimon Kelly 31
345728285
MEASURED ENERGY EXPENDITURE IN CRITICALLY ILL BURN PATIENTS CORRELATES 
WITH TIME POST-INJURY BUT NOT BURN SIZE
Dr. Susannah King 31
345716654
DOES BARIATRIC SURGERY CAUSE MICRONUTRIENT DEFICIENCY?: A SYSTEMATIC 
REVIEW
Ms. Carrie-Anne Lewis 32
345720847
A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CRITERION VALIDITY OF 
NUTRITION ASESSMENT TOOLS FOR DIAGNOSING PROTEIN-ENERGY MALNUTRITION 
IN THE OLDER COMMUNITY SETTING 
Dr. Skye Marshall 32
345601092
THE EFFECT OF RESVERATROL ON COGNITIVE PERFORMANCE: A SYSTEMATIC 
LITERATURE REVIEW AND META-ANALYSIS 
Dr. Wolfgang Marx 33
345273811
A MODEL FOR ESTABLISHMENT OF A DIETITIAN LED GASTROENTEROLOGY CLINIC IN A 
LARGE TERTIARY HOSPITAL IN AUSTRALIA 
Ms Rumbidzai 
Mutsekwa
33
345274333
RETROSPECTIVE EVALUATION OF A DIETITIAN LED GASTROENTEROLOGY CLINIC 
AND ITS IMPACT ON A TERTIARY GASTROENTEROLOGY SERVICE IN SOUTHEAST 
QUEENSLAND
Ms Rumbidzai 
Mutsekwa 
34
345617107
ASSESSING THE AGREEMENT BETWEEN PATIENTS AND DIETITIAN, AND THE USABILITY 
OF THE PG-SGA AND PT-GLOBAL APP IN THE AUSTRALIAN ONCOLOGY SETTING
Miss Astrid  Naranjo 34
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345711531
PANCREATIC EXOCRINE INSUFFICIENCY AND NUTRITIONAL OUTCOMES AFTER 
PANCREATIC RESECTION
Miss Yue Xian (Selena) 
Ooi
35
345691174
THE IMPACT OF PANCREATIC RESECTION ON QUALITY OF LIFE - AN OBSERVATIONAL 
COHORT STUDY
Ms Karen Percy 35
345759959
PRE-OPERATIVE MALNUTRITION IS A PREDICTOR OF POST-OPERATIVE OUTCOMES IN 
PERITONECTOMY SURGERY 
Ms Lauren Reece 36
344826182
CHILDHOOD OBESITY:AN EMERGING CHALLENGE IN INDIA Dr. Bhuvaneshwari 
Shankar
36
345067569
DOES HYPOCALORIC FEEDING IMPACT THE OUTCOME OF CRITICALLY ILL WITH 
INCREASED BMI?
Dr.  Bhuvaneshwari 
Shankar
37
345711028
NUTRITIONAL ASSESSMENT AND SUPPORT IN PAEDIATRIC CANCER PATIENTS 
UNDERGOING CHEMOTHERAPY
Dr.  Bhuvaneshwari 
Shankar
37
329981024
CLINICAL BENEFITS OF EARLY AND EXTENDED NUTRITIONAL INTERVENTION IN OLDER 
PATIENTS DISCHARGED FROM ACUTE CARE- A RANDOMIZED CLINICAL TRIAL
Dr. Yogesh Sharma 38
345729331
IMPROVING NUTRITION CANCER CARE OUTCOMES - FINDINGS FROM A STATE-WIDE 
BENCHMARKING PILOT STUDY
Ms Natalie Simmance 38
345749499
EFFECTS OF SUBSTITUTION OR ADDITION OF CARBOHYDRATE AND FAT TO PROTEIN 
SUPPLEMENTS ON GASTRIC EMPTYING, GUT HORMONES AND ENERGY INTAKE IN 
HEALTHY OLDER MEN
Dr. Stijn Soenen 39
345777698
CLINICAL OUTCOMES OF PATIENTS WITH TYPE III INTESTINAL FAILURE. A 12 YEAR 
REVIEW OF A SINGLE CENTRE'S EXPERIENCE 
Miss Shanice Sri 39
339010320
HOME ENTERAL NUTRITION SERVICES AT PUBLIC HOSPITALS IN NEW SOUTH WALES, 
AUSTRALIA
Ms Diana  Tang 40
345692665
PLATINUM-INDUCED FATTY ACIDS ARE PRESENT IN CANCER PATIENTS BUT MAY NOT 
BE ASSOCIATED WITH TREATMENT RESPONSE
Ms Laisa Teleni 40
345693405
DEPRESSED MOOD AND COGNITIVE FUNCTIONS IN PATIENTS WITH CANCER ARE 
ASSOCIATED WITH ALTERATIONS IN TRYPTOPHAN METABOLISM
Dr. Barbara van der 
Meij
41
345720269
AN AUDIT OF THE POSTOPERATIVE NUTRITIONAL PRACTICES FOLLOWING MAJOR 
ABDOMINAL SURGERY
Miss Jessie Varghese 41
345715050
MULTIDISCIPLINARY EVIDENCE-BASED INTESTINAL REHABILITATION: CASE REVIEW OF 
OPTIMAL OUTCOMES DESPITE POOR PROGNOSTIC FACTORS
Dr. Boutaina Zemrani 42
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345748034
IMPLEMENTATION AND EVALUATION OF SELF ADMINISTERED 
MALNUTRITION SCREENING IN GASTROENTEROLOGY 
OUTPATIENTS
Amy Allia 1,2, Dr. Jakob Begun 1,2,3, Heidi Harris 1, Ra’eesa 
Doola 1,2.
1 Mater Group, South Brisbane, Australia
2 Mater Research Institute - The University of Queensland, 
South Brisbane, Australia
3 University of Queensland School of Medicine, Brisbane, 
Australia
Background: An audit of our tertiary centre inflammatory 
bowel disease (IBD) outpatient clinic revealed a malnutrition 
prevalence of 16%1 with no routine malnutrition screening 
in place. In collaboration with the multiple disciplines 
operating in the IBD clinic, dietetics led the development and 
implementation of a patient administered allied health (AH) 
screening tool, incorporating the Malnutrition Screening Tool 
(MST). The aim of the tool was to identify at risk patients 
to better facilitate nutrition and other discipline specific 
optimisation of care and to monitor efficacy of interventions in 
a longitudinal manner. 
Methods: A multidisciplinary screening tool was developed 
in consultation with IBD Nursing staff and the AH team and 
approved by the relevant hospital committee. A literature 
review as well as patient feedback was used to inform this 
process. An audit of screening processes and responses took 
place between February and March in 2016. 
Results: A well-constructed, easily administered tool was 
implemented. Audit results indicated the following:
n % of audit 
population
Patients attending clinic audited 114
IBD 66 58
Consent to allied health 
referral
61 65
Positive MST 22 19
Within three months of positive MST 
screen:
Seen a Dietitian
Dietitian appointment 
scheduled
Declined referral
Not seen/no appointment 
booked
9
6
5
2
41
27
23
9
Patients scoring higher on an MST were more likely to score 
highly on the Patient Health Questionnaire for Depression 
and Anxiety (PHQ-4) (p=<0.05). Of patients screening positive 
on MST only 3 were known to dietetics prior to the positive 
screen. 
Conclusions: There are many challenges in implementing a 
screening tool and achieving adequate response from patients 
with self screening measures. However, malnutrition screening 
highlights patients not otherwise known to dietetics who 
may otherwise not be identified. Patients with a higher risk 
of malnutrition also displayed higher risk for depression and 
anxiety and their needs are bessed addressed in a multi-
disciplinary setting. 
References: Pulley, J. 2015. Journal of Gastroenterology and 
Hepatology, 30(S3): 163.
345687906
TOLERABILITY OF EARLY ENTERAL NUTRITION POST 
ALLOGENEIC STEM CELL TRANSPLANTATION- A RANDOMISED 
COMPARISON TO STANDARD CARE
Sarah Andersen1,2, Dr. Nicholas Weber1, Dr. Merrilyn Banks1, 
Teresa Brown1, A/Prof. Glen Kennedy1, A/Prof. Judy Bauer2
1 Royal Brisbane and Women’s Hospital, Brisbane, Australia 
2. The University of Queensland, Brisbane, Australia
Background: 
Nutrition support is an important component of care to 
prevent malnutrition during allogeneic haematopoietic stem 
cell transplantation (HPCT) however there is no consensus on 
the optimal method of supplementary feeding. Some small 
non-randomised studies have indicated that enteral nutrition 
(EN) when compared to parenteral nutrition (PN) may improve 
patient outcomes however there remains some uncertainty 
about the tolerability of nasogastric feeding in this patient 
group.This randomised study aimed to determine whether 
proactive early EN is tolerable in comparison to standard care. 
Methods: 
Patients were recruited pre transplant and randomised to early 
EN or standard care. The EN group had a fine bore nasogastric 
tube inserted the day after stem cell infusion and feeding 
commenced at 30ml/hr. As oral intake declined the rate of 
feeding was increased to goal. If patients were intolerant 
of EN they were converted to PN if required. The standard 
care group commenced PN when oral intake was <60% of 
requirements for three days and was unlikely to improve for 
another week. 
Results: 
Forty four patients (mean age 48+14.4; 25 male, 19 female) 
were enrolled in the study (March 2015- May 2017) and 
randomised to EN (n=22) or standard care (n=22). In the EN 
group 11 tolerated EN (50%), 9 changed to PN and 2 withdrew 
from study. The median duration of EN was 9 days (1-22) and 
patients met 78% of goal nutrition. In the standard care group 
68% required PN, the median duration was 12 days (6-33) and 
patients met 95% of goal nutrition.  
Conclusions: 
Half of patients receiving myeloablative allogeneic 
transplantation tolerate EN. As this will significantly reduce the 
use of PN and its associated complications and cost, EN should 
be considered as first line nutritional support. 
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345294228
DIETITIANS AT THE POINTY END: INSERTION OF 
NASOGASTRIC TUBES 
Presenting Author 1 Rhonda Anderson, 
2 Ms Laure Baumgartner
3 Ms Bernadette Sellwood
1 Cairns and Hinterland Hospital and Health Service, Cairns, 
Australia
2 Cairns Hospital, Cairns, Australia
3 Cairns Hospital, Cairns, Australia
Background: 
Currently within Cairns and Hinterland Hospital and Health 
Service (CHHHS), registered nurses (RN’s) or medical 
officers (MO’s) insert nasogastric tubes (NGT) and MO’s 
order radiography to confirm tube placements. High 
workload demands often result in delayed tube placement 
and subsequent feeding in in- and outpatient settings.  
Credentialed dietitians are well placed to insert/manage 
NGT due to their involvement in enterally fed patients. To 
our knowledge this practice is yet to be implemented in 
Australia. The expected benefits are: improved patient access; 
reduced delays in commencing enteral feeding; reduced 
demand on RN’s and MO’s for NGT insertion/management 
and radiography orders; reduced patient presentations to 
Emergency Department for NGT insertions/ management; 
enhanced clinician skill mix. The aim was to propose and 
implement a model of care where dietitians insert and manage 
NGT utilising extended scope of practice. 
Methods: 
A learning package, which included theory, simulation and 
practical skills  was developed collaboratively by nurse 
educators and dietitians; dietitian competency was assessed 
by Nurse Educators. CHHHS procedures and internal protocols 
for insertion/management of NGT, radiography orders and 
radiation safety training were developed in consultation with 
nursing, gastroenterology and medical imaging departments; 
clinical governance was provided by the Gastroenterology 
Department. 
Results: 
The new model of care was approved by CHHHS Allied Health 
Credentialing and Scope of Clinical Practice Committee in 
December 2016. Four senior dietitians have completed the 
learning package, with three having completed competency 
assessments with one in progress. These dietitians will now 
seek individual credentialing and once this is achieved the 
service will begin.
Conclusions: 
This model of care utilising extended scope of practice by 
dietitians is approved by the CHHHS and credentialing for 
individual dietitians is in process. Once operational, the 
service will be evaluated utilising audit tools and stakeholder 
satisfaction surveys.  
345302280
WHAT’S THE MISSING PIECE OF OUR PARENTERAL PUZZLE? 
Presenting Author Emma Armstrong1, Lina Breik1, Erin 
Brennan1, Gene Chai1, Renata Mistarz1, Dr. Tissa Tandiari1,  
Dr. Graeme Duke1.
1Eastern Health, Melbourne, Australia
Background: Multidisciplinary team collaboration is the 
hallmark of excellence in parenteral nutrition (PN) therapy. 
This audit aimed to identify gaps in the PN service of a 
large metropolitan, university-affiliated, hospital (70,000 pa 
inpatient admissions).
Methods: A bimodal approach was undertaken: (1) Analysis of 
all internal audits in the last 12-months; (2) Literature review 
to determine best practice; summarised by the following:  
(A) Does the PN team:
Include experienced physicians, dietitians, nurses and 
pharmacists?
Provide daily patient assessment?
Document PN orders and progress?
Facilitate transition to enteral nutrition?
(B) Does the PN team have:
Established performance/measurable goals? 
Regular audits of complications e.g. electrolyte disorders, liver 
dysfunction, refeeding syndrome, malnutrition scores?
Simple, reliable, centralised data collection processes? 
Regular review of service delivery and patient outcomes?
Results: The PN team is run by the Intensive Care Unit (ICU), 
Dietetics and Pharmacy. In 2016, 64 patients received 728 
bags of PN. Average daily cost of formula was $187 and cost 
pa $68,068. Median number of days on PN was 8 (range 1 – 
129). Majority were male (69%), surgical (73%) patients. A 
6-month audit identified no sepsis or death complications, 
liver dysfunction in 37% and refeeding syndrome in 8%. 
The PN service scored 4/4 and 0/4 under Section (A) and 
(B), respectively, of the above questions. There were no 
performance goals or frequent audit processes. 
Conclusions This audit identified specific gaps and measurable 
outcomes. The PN team is present and functioning but missing 
some crucial elements for a safe and effective service: clear 
goals and clinical audit procedures. The PN team is now better 
informed to determine these goals and measures to track 
progress.   
References: Schneider, P.J., 2006. Nutrition support teams: 
an evidence-based practice. Nutrition in Clinical Practice, 
21(1),62-67.
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345729541
PREVALENCE OF MALNUTRITION, NUTRITIONAL PROFILE AND 
LENGTH OF STAY IN RENAL INPATIENTS
1Bahceci, S., 2Evans,K., 1Chan, M.
1St George Hospital, Kogarah, NSW, Australia
2The Sutherland Hospital, Caringbah, NSW, Australia
Background:
Malnutrition is common among renal patients, and is 
associated with morbidity, mortality, and hospitalisation 
including increased length of stay (LOS). This study aimed 
to examine the relationship between the clinical profile, 
prevalence of malnutrition, and LOS in a cohort of renal 
patients admitted to an acute tertiary hospital.
Methods:
A retrospective audit was conducted on data routinely 
collected for patients admitted under the renal medicine 
team over 11 months. Data collected included demographics, 
clinical presentation, LOS, nutritional profile including 
Subjective Global Assessment (SGA) score, history of dietitian 
involvement and the need for dietitian follow up post 
discharge.
Results:
Records of 218 patients were reviewed. The average number 
of renal admissions was 12.8±3.9 per day, with 45.4±15.9% 
of patients under the care of the dietitian, either referred or 
automatic referral as per department policy. 
The mean age of patients was 68.0±14.3 years. The prevalence 
of malnutrition was 63.6% (SGA=B and C). The LOS period 
between well nourished (SGA=A) vs. malnourished (SGA=B and 
C) was 12.2±11.5 vs. 16.5±22.6 days respectively, p=0.09 and 
was considered clinically significant. All malnourished patients 
required ongoing nutrition support by dietetics post discharge. 
Conclusions:
Malnourished renal inpatients tended to have longer LOS 
which as implications for clinical practice. Malnutrition 
management prior to, during, and after hospital discharge 
is likely to make a difference to LOS. Therefore, a 
multidisciplinary team approach to early identification of 
malnutrition for dietetic referral is vital to ensure continuum of 
care.
345729553
THE VALIDITY OF MULTI-FREQUENCY BIOELECTRIC 
IMPEDANCE METHODS TO MEASURE BODY COMPOSITION IN 
OBESE PATIENTS: A SYSTEMATIC REVIEW
Louise Becroft1, Dr. Audrey Tierney2, Geraldine Ooi3
1The Alfred Hospital, Melbourne, Australia,
2La Trobe University, Melbourne, Australia,
3Monash University Centre for Obesity Research and 
Education, Melbourne, Australia 
Background: Obesity is a widespread burden affecting the 
community, with obesity rates growing globally.  Although 
weight loss is advocated for overall better metabolic health, 
excessive loss of lean body mass may have serious metabolic 
consequences.  Thus, accurate body composition assessment 
methods for obese patients are required to monitor fat loss 
and ensure lean muscle maintenance, enabling functional 
gains and quality of life improvements during aggressive 
weight loss programmes.  Bioelectrical Impedance (BI) is a 
simple way of assessing body composition and has gained 
popularity for clinical use due to its convenience, low cost and 
instant results.  The aim of this review was to investigate if BI is 
a valid tool to determine body composition in morbidly obese 
patients compared to reference methods.
Methods: MEDLINE, EMBASE, CINAHL and CENTRAL databases 
were searched until March 2017.  Included studies were those 
published in English with obese (body mass index (BMI) ≥30kg/
m2) adults (≥18 years) measuring body composition with BI 
methods in comparison to pre-determined reference methods.
Results:. 16 studies were eligible for inclusion.  Sample sizes 
ranged from n= 15 to 157, with BMI 26 to 48kg/m2.  BI 
underestimated Fat Mass (FM) and overestimated Fat Free 
Mass (FFM) in 10 studies in comparison to reference methods 
for obese subjects.  The correlation of absolute values from 
BI and reference methods for FM and FFM were high (r=0.53-
0.97).  When adjustments for BMI were made to BI machine 
algorithms, the accuracy of body composition measurements 
were improved.  Significant heterogeneity was evident 
amongst included studies and prevented meta-analysis.
Conclusions: Multiple variables, including study numbers, 
methodologies, algorithms and outcome reporting contributed 
a lack of consistency amongst studies and therefore validity of 
BI to assess body composition in obese patients is difficult to 
determine.  This review highlighted the need for more robust 
studies that control confounding variables to establish clear 
validity statements.
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345724017
ENTERAL NUTRITION SUPPORT AND TREATMENT TOXICITIES 
IN PATIENTS WITH HEAD AND NECK CANCER RECEIVING 
HELICAL INTENSITY-MODULATED RADIOTHERAPY WITH 
CONCURRENT CHEMOTHERAPY 
Claire Blake 1, Teresa Brown 1, Anita Pelecanos 2, Laura 
Moroney 1, 3, Jennifer Helios 1, Brett Hughes 1,3, Liz Kenny 1,3
1 Royal Brisbane and Women’s Hospital, Brisbane, Australia
2 QIMR Clive Berghofer Medical Research Institute, Brisbane, 
Australia
3 University of Queensland, Brisbane, Australia
Background: Weight loss in patients with head and neck cancer 
(HNC), often associated with inadequate nutritional intake, 
is affected by multiple factors including acute toxicities of 
treatment. Enteral nutrition support is often required to meet 
nutrition and hydration requirements during helical intensity-
modulated radiotherapy with concurrent chemotherapy 
(chemoH-IMRT). Although highly sophisticated radiotherapy 
provides excellent limitation of dose to tissues not requiring 
treatment, acute toxicity still occurs within high dose volumes. 
The aim of the study is to determine the relationship between 
acute toxicities in patients receiving chemoH-IMRT and the 
requirement for enteral nutrition support. 
Methods: Prospective study of patients with HNC, primarily 
oropharyngeal, with a proactive gastrostomy in situ 
undergoing chemoH-IMRT (n=74). Baseline dysphagia was 
defined as a Functional Oral Intake Scale score less than or 
equal to 5.  Acute toxicity and enteral nutrition data were 
collected weekly during treatment using the CTCAE v4.0. 
Enteral nutrition intake was calculated as a percentage of 
estimated nutrition requirements.
Results: Enteral nutrition support was commenced in 88% 
(n=65) of patients. Oral mucositis, pharyngeal mucositis, 
dysguesia, thick saliva and baseline dysphagia were all 
significantly associated with the outcome of enteral feeding 
over time (p<0.05). Patients experiencing Grade 3 toxicities for 
dysphagia, pharyngeal mucositis, oral mucositis or thick saliva 
or Grade 2 or 3 nausea had the greatest propensity for enteral 
nutrition support of 50% or greater of estimated nutrition 
requirements (p<0.05).
Conclusions: There was a high rate of enteral nutrition in 
patients with HNC undergoing chemoH-IMRT. Requirements 
for enteral nutrition support was primarily associated with 
grade 3 acute toxicities related to treatment protocols. The 
results indicate that weekly monitoring of toxicities can be 
a useful predictor for clinicians to initiate enteral nutrition 
support.
345300391
ENTERAL NUTRITION – EVIDENTLY NOT!
Presenting Author Lina Breik1, Pratibha Ganu1, Erin Brennan1, 
Dr. Graeme Duke1
1Eastern Health, Melbourne, Australia
Background: Enteral nutrition (EN) in critically ill patients has 
“moderate” to “high” supporting evidence. This audit aimed 
to identify gaps in the current protocol of a large metropolitan, 
university-affiliated, hospital (70,000 pa inpatient admissions).
Methods: A multi-modal multi-site approach was undertaken, 
inclusive of; (a) a literature review, (b) a retrospective audit of 
20 medical records (ie. patients intubated >48hrs), and (c) a 
fishbone anaylsis with intensive care unit (ICU) staff. 
Results:
Aspect of EN Current Practice Best Practice
Nutritional 
adequacy
63%. 100%.
Starting EN 
rate
Varies 20-60mls/hr. Target rate.
Prokinetic 
agent
Metoclopramide 
10mg IVqid.
Metoclopramide 
10mg IVqid PLUS 
Erythromycin 
200mg IVbd.
Prokinetic 
duration
Clinical judgement. Maximum 72hrs.
GRV 
threshold
200-250ml. >500ml.
Monitoring 
intolerance
Only gastric aspirate 
volume.
Gastric aspirate 
volume and clinical 
signs of feed 
intolerance.
Conclusion: Variations exist in starting rate, prokinetic 
prescribing and gastric aspirate threshold between the sites 
and are suboptimal compared with best practice, evidently 
leading to inadequate nutrition provision. Education of staff 
and revision of the existing EN protocol to align  with best 
practice is underway, aiming for complete implementation by 
March 2018.
References: Guidelines for the Provision and Assessment of 
Nutrition Support Therapy in the Adult Critically Ill Patient. 
Journal of Parenteral and Enteral Nutrition;  February 2016 
(40;2).
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339848783
ASSESSING TREATMENT OPTIONS FOR INTESTINAL FAILURE 
PATIENTS USING TIME TRADE-OFF METHODOLOGY.
Sharon Carey1,2, Wendy Tu2, Lynn Jones1, Cherry Koh1,2
1Royal Prince Alfred Hospital, Sydney, Australia 
2The University of Sydney, Sydney, Australia
Background: There are limited management options available 
in Australia for people with Type III intestinal failure, with 
home parenteral nutrition (HPN) being the main treatment 
option. This research aims to evaluate how many years of 
life people on HPN are willing to trade when presented with 
a range of treatment options, including those not readily 
available in Australia.
Methods: An interviewer-administered telephone survey was 
conducted on a cross sectional cohort of 19 HPN participants. 
The survey was designed to measure health-related quality 
of life (HRQOL) using a time trade-off methodology. Four 
different treatment options were presented, and participants 
decided how many years of life they would trade to have 
access to the treatment and hence a different health state. 
The four scenarios included optimization of current care; line 
infections; access to a glucagon-like peptide-2 (GLP-2) analog; 
and intestinal transplantation. Health state utility scores were 
calculated.
Results: The median health utility score for optimisation of 
current care and access to a glucagon-like peptide-2 (GLP-2) 
analog were lowest (0.5; range 0-1) meaning a greater desire 
for this treatment. Small bowel transplant had the highest 
median utility score (1.0; range 0-1) indicating less willingness 
for this treatment option. 
Conclusions: This is the first known study to use time trade-
off methodology in people with HPN. Results indicate that 
people requiring HPN make careful decisions when considering 
treatment options. Facilities providing HPN services should 
focus on optimisation of current care, which is highly valued by 
their patients.   
339849148
DEVELOPMENT OF CONSENSUS ON MODELS OF CARE IN 
ADULTS WITH INTESTINAL FAILURE USING A MODIFIED 
DELPHI APPROACH. 
Sharon Carey1,2, Michelle Kalachov 2, Lynn Jones1, Cherry 
Koh1,2
1 Royal Prince Alfred Hospital, Sydney, Australia 2 The 
University of Sydney, Sydney, Australia
Background: Currently, lack of evidence and ad hoc service 
delivery models means there is no coordinated or defined 
model of best-practice for adult Type III intestinal failure 
(IF) services in Australia. The objective of this research 
was to establish consensus on service delivery models for 
management of Type III IF within the Australian health care 
system and to identify barriers and enablers in moving towards 
this ideal model. 
Methods: A modified Delphi methodology was utilized to 
survey experts working in Type III IF. Physicians, dietitians, 
nurses and pharmacists from all 19 adult Type III IF centres 
across Australia participated. The study consisted of two 
rounds of email administered questionnaires developed 
around four key areas of health service delivery: access to 
services, clinical care, service guidance and models of care. 
Responses were evaluated via inductive thematic approach. 
Experts reviewed the final report to consolidate consensus and 
validity.
Results: Consensus was achieved on the makeup of an ideal 
team, the need for guidelines and an ideal model of care for 
this patient group.  However, further consultation is required 
in order to establish consensus around the use of home 
parenteral nutrition in the palliative oncology setting. 
Conclusions: This research is the first to explore models of care 
for intestinal failure within the Australian setting. It allows a 
framework for health professionals, managers, policy makers, 
and consumer groups to move towards optimal management 
for Type III IF patients. 
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335058471
APPETITE AND NUTRIENT INTAKE IN SURVIVORS OF CRITICAL 
ILLNESS 
Lee-anne S. Chapple 1,2,3, Luke M. Weinel 2, Yasmine Ali 
Abdelhamid 1,2, Matthew J. Summers 2
Thu Nguyen 1, Palash Kar 1, Kylie Lange 3, Marianne J. 
Chapman 1, 2, 3, Adam M. Deane 1,3,4
1Discipline of Acute Care Medicine, School of Medicine, 
University of Adelaide, Adelaide, Australia.
2Intensive Care Research Unit, Royal Adelaide Hospital, 
Adelaide, Australia.
3National Health and Medical Research Council of Australia 
Centre for Clinical Research Excellence in Nutritional Physiology 
and Outcomes, Adelaide, Australia. 
4Intensive Care Unit, Royal Melbourne Hospital, Melbourne, 
Australia
Background: 
Oral intake is diminished immediately after intensive care unit 
(ICU) discharge, yet factors affecting nutritional intake after 
hospital discharge have not been evaluated. We aimed to 
evaluate factors which determine nutritional status - appetite, 
dietary intake and gastric emptying - 3-months after ICU 
discharge.
Methods: 
We conducted an inception cohort study comparing ICU 
survivors to healthy subjects. Following an overnight fast, all 
participants consumed a standardised carbohydrate drink, 
containing 13C-octanoic acid, to measure gastric emptying. 
Dietary intake was assessed by recall of the preceding day and 
a standard weighed buffet meal 4-hours post-drink. Appetite 
was assessed pre-drink (fasting) and pre- and post-buffet using 
visual analogue scales.
Results: 
Fifty-one ICU survivors (82% male; 70±9y; BMI 28±6kg/m2) 
and 25 healthy subjects (60% male; 67±12y; BMI 27±4kg/
m2) were evaluated. From the 24-hour recall ICU survivors 
consumed less calories (ICU 1876 (708) vs. health 2291 (834) 
kcal; p=0.025) and had less preference for fat than healthy 
subjects (p<0.001). Oral intake of all macronutrients from the 
weighed buffet was similar in the two groups: calories (ICU: 
658 (301) vs. health: 736 (325) kcal; p=0.149); protein (ICU: 
37 (19) vs. health: 40 (17) g; p=0.275); fat (ICU: 23 (12) vs 
health: 26 (13) g; p=0.261); and carbohydrates (ICU: 69 (35) 
vs. health: 79 (42) g; p=0.141). ICU survivors reported lower 
fullness ratings regardless of time-point (p=0.041). There was 
no difference in the rate of gastric emptying between the two 
groups (p=0.216).
Conclusions: 
ICU survivors reported less preference for fat and less calorie 
consumption than in health. However, actual measured intake 
of calories and macronutrients was similar in the two groups, 
as was the rate of gastric emptying. ICU survivors reported 
lower fullness ratings after the test meal, suggesting factors 
other than appetite may influence intake.
337486912
DIETITIAN PRESCRIBED NUTRITIONAL SUPPLEMENTS IN THE 
MEDICATION CHART LEADS TO INCREASED ENERGY AND 
PROTEIN INTAKES
Megan Ritchie, Sally Courtice, John Parke
Queen Elizabeth II Jubilee Hospital, Brisbane, Australia
Background: Recent data indicates approximately 30% of 
hospital patients are malnourished, for some patients it is not 
possible to meet nutritional requirements through oral diet, 
standard nutrition supplements, and may not be appropriate 
for enteral feeding. Supplements as Medicine (SAM) is the 
provision of high energy (2kcal/mL) and protein supplements 
to patients in manageable amounts (typically 80mL three 
times/day or 60mL four times/day). The aim of this project 
was to evaluate the effectiveness of dietitians prescribing SAM 
directly into the medication chart.
Methods: The SAM process was evaluated in June 2017 and 
compared with 2016 results prior to dietitians prescribing. 
Medication and end of bed charts were audited. 
Results: 8 patient charts were audited in 2017 (representing 
143 occasions of SAM prescribed) compared with 19 patients 
in 2016. 
Comparison of dietitians prescribing SAM 2017 to pre-
implementation 2016
0% 1% 2%
94%
32%
13% 9%
77%
0%
20%
40%
60%
80%
100%
Lost data SAM not
given
without
reason
SAM
refused by
patient
SAM
accepted by
patient -
excluding
lost data
Dietitians prescribing SAM
(2017 data)
Prior to dietitians
prescribing (2016 data)
Average energy and protein intake from SAM in 2017 was 
1861kJ and 18.5g versus 2016 of 1533kJ and 15g. 
Conclusions: Dietitians prescribing SAM in the medication 
chart leads to an increase in energy and protein intake. 
Prior to dietitians prescribing, lost documentation occurred 
in 32% of cases, it is presume that 1/3 of patients did not 
receive the supplements recommended. After prescribing 
commenced there was no lost documentation. Acceptance 
of SAM increased after prescribing from 77% (excluding lost 
documentation) to 94%. This increase in uptake led to an 
average increase in energy intake from 1533kJ to 1861kJ 
and protein intake of 15g to 18.5g. Dietitians prescribing 
SAM in the medication chart improves documentation, 
improves uptake of supplements by patients, and leads to 
an increase in energy and protein intake. Allowing dietitians 
to prescribe directly into the medication chart should be 
utilised as a strategy to assist in the treatment of hospitalised 
malnourished patients.
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345712776
DIETARY FIBRE MODIFICATION WITH OR WITHOUT 
ANTIBIOTICS IN THE PREVENTION OF DIVERTICULITIS IN 
ADULTS WITH DIVERTICULAR DISEASE: A SYSTEMATIC 
LITERATURE REVIEW AND META-ANALYSIS.
Megan Crichton 1, Camilla Dahl 2, Julie Jenkins 3, Romina 
Nucera 4, Wolfgang Marx 5, Hannah Mackay 6, Skye Marshall 
7
1, 2, 7 Bond University, Gold Coast, Australia
3, 4 Robina Hospital, Gold Coast, Australia
5 Latrobe University, Melbourne, Australia
6 Mater Hospital Brisbane, Brisbane, Australia
Background: The use of high dietary fibre intake and antibiotics 
have been hypothesised to play a role in the management 
of diverticular disease; however, dietary recommendations 
for the prevention of diverticulitis in those with diverticular 
disease are inconsistent and quality evidence is lacking. 
Therefore, this systematic review aimed to pool and appraise 
existing data to explore the effect of dietary fibre modifications 
with or without antibiotics on the development of acute 
diverticulitis, gastrointestinal symptoms and bowel habits in 
adults with diverticular disease.
Methods: Five electronic databases were searched for studies 
from database inception until March 2017. Studies were 
critically appraised and pooled using meta-analysis.
Results: 20 studies were included. Compared with placebo, 
ispaghula husk supplementation significantly increased 
daily stool weight by μ42g/day (95%CI:26-57g; P<0.00001); 
however, dietary fibre supplementation inconsistently 
improved gastrointestinal symptoms and transit times 
depending on baseline values, and no studies evaluated its role 
in preventing diverticulitis. Seven days to everyday per month 
for 12-24-months of dietary fibre supplementation had a 2.6 
(95%CI:1.24-5.6; P=0.01) higher relative risk of diverticulitis 
compared to dietary fibre and poorly-absorbed antibiotic co-
administration. Seven days every month for 12-24-months 
or 14 days of dietary fibre and poorly-absorbed antibiotic 
co-administration significantly decreased gastrointestinal 
symptoms compared with dietary fibre supplementation alone 
by a standardised mean of 1 point (scale of 0 to approximately 
18) (95%CI:0.70-1.21; P<0.00001).
Conclusions: Dietary fibre supplementation may improve 
bowel function and gastrointestinal symptoms in those 
with diverticular disease; but its role in the prevention 
of diverticulitis is unknown. Although co-administration 
with poorly-absorbed antibiotics appears to have superior 
effects compared to dietary fibre supplementation alone; 
recommendations for this are not supported due to the high 
risk of bias in existing research. 
345368122
THE VALIDITY OF PATIENT-LED  SCREENING USING 
THE MALNUTRITION SCREENING TOOL (MST) IN THE CANCER 
CARE AMBULATORY SETTING
Alexandra Di Bella 1, Emilie Croisier 2, Claire Blake 3, Anita 
Pelecanos 4, Teresa Brown 5 
1 B HlthSci (Nutr&Diet) (Hons), Accredited Practising Dietitian, 
Nutrition and Dietetics, Royal Brisbane and Women’s Hospital, 
Herston, Queensland 4029
Corresponding author. Australia. Telephone: +61 7 3646 8268, 
Email: Alexandra.dibella@health.qld.gov.au
2 B ExNutr Sciences, M Dietetics Studies, School of Human 
Movement and Nutrition Sciences, The University of 
Queensland, St Lucia, 4072, Australia; Presenting author
3 B HlthSci (Nutr&Diet) (Hons), Accredited Practising Dietitian, 
Nutrition and Dietetics, Royal Brisbane and Women’s Hospital, 
Herston, Queensland, 4029, Australia
4 B HlthSci (Nutr&Diet) (Hons) BSc (Hons), Statistics Unit, QIMR 
Berghofer Medical Research Institute, Herston, Queensland, 
4006, Australia
5 BSc NutrSci (Hons) PostGradDipNutr&Diet, Advanced 
Accredited Practising Dietitian, Nutrition and Dietetics, Royal 
Brisbane and Women’s Hospital, Herston, Queensland, 4029, 
Australia
Background: Malnutrition is prevalent in the cancer care 
ambulatory setting. Much of the existing literature and 
various international frameworks have demonstrated the 
benefits of nutrition screening in facilitating early prevention 
and treatment for patients at risk of malnutrition. The 
Malnutrition Screening Tool (MST) has been validated for use 
by healthcare professionals in cancer care to detect at-risk 
patients. However there is a gap in the literature regarding 
validation of patient-led screening with the MST  against the 
Subjective Global Assessment (SGA).
Methods: A single site cross-sectional observational study was 
undertaken in an oncology day therapy unit at a Queensland 
metropolitan teaching hospital in a convenience sample 
of 201 patients attending the unit for chemotherapy or 
supportive therapies. Patient self-administered MST scores 
were collected and compared to the MST and SGA scores 
completed by dietitians.
Results: As indicated by the SGA score, 82% of patients were 
categorised as well-nourished (SGA A) in comparison to 18% as 
malnourished (SGA B or C). Conversely, 71% of patients were 
considered not-at-risk of malnutrition in comparison to 29% 
at-risk, according to the patient self-administered MST scores. 
The inter-rater reliability of the patient MST score with the 
dietitian MST score was high as indicated by an overall 94% 
agreement for risk category (0-1=not-at-risk; >=2=at-risk) and 
a correlation of 0.85. The ability of the patient-led screening 
with the MST to predict nutrition status was assessed and 
found to have a sensitivity of 94% and specificity of 85%. The 
positive predictive value was 0.58 and the negative predictive 
value was 0.98. 
Conclusion: When administered by patients, the MST has been 
shown to be a simple and valid tool that can reliably identify 
patients as at-risk or not at risk of malnutrition.  
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345294126
TRANSLATION OF DIETITIAN-LED GASTROSTOMY 
MANAGEMENT MODEL OF CARE IN A REGIONAL FACILITY
Kara Cronin1, Rhonda Anderson2, Sean Field3, Debra 
Whittaker4
1 Nutrition and Dietetics, Cairns Hospital,Cairns, Australia
2 Nutrition and Dietetics, Cairns Hospital,Cairns, Australia
3 Endoscopy Unit, Cairns Hospital, Cairns, Australia
4 Endoscopy Unit, Cairns Hospital, Cairns, Australia
Background: Royal Brisbane and Women’s Hospital (RBWH) 
has a well-established dietitian-led model of care (MOC) 
for dietitians’ expanded scope of practice in management 
of gastrostomy devices1.  In December 2015, a Cairns 
Hospital dietitian attended the RBWH training program; upon 
completion, credentialing in expanded scope of practice in 
the Management of Gastrostomy Tubes approved by the 
Cairns & Hinterland Hospital and Health Service (CHHHS) 
Allied Health Credentialling Committee.  It is expected the 
implemented dietitian-led gastrostomy service at Cairns 
Hospital demonstrates a timely, appropriate and safe MOC in a 
regional hospital; and that staff and patients have a high level 
of acceptability and satisfaction with the service.
Method: Data has been collected on the nature and outcome 
of interventions delivered in the service and independently 
reviewed by a senior endoscopy nurse; along with supervision 
of practice.  All patients were provided with a satisfaction 
survey on completion of their care.  Staff satisfaction surveys 
will be disseminated in October 2017.  Data collation is 
expected to be completed November 2017.
Results: At August 2017, 18 patients had received care from 
the service; all of the interventions trained to be delivered 
were provided in the MOC.  The service potentially prevented 
an additional 19 occasions of service through provision of 
interventions to treat minor complications at a planned 
nutrition review that would have previously required referral 
to nursing or medical staff.  Preliminary results of patient 
satisfaction surveys indicated excellent satisfaction with the 
service.  
Conclusions: This study shows that expanded scope of practice 
models of care can be safely and appropriately implemented 
by dietitians in regional facilities with a high level of patient 
acceptability.  This MOC improves access to gastrostomy care 
and decreases clinical transactions; presenting an opportunity 
for cost savings and efficiencies. 
References:
Blake C, Banks M, Brown T, Appleyard M.   Expanding extended 
scope of practice for dietitians: management of gastrostomy 
tubes and cares.  Royal Brisbane and Women’s Hospital.  
http://www.nahc.com.au/papers/nahc2015abstract00046.pdf 
345686519
EVIDENCE FOR DIETARY FIBRE MODIFICATION IN THE 
PREVENTION OF ACUTE, UNCOMPLICATED DIVERTICULITIS: A 
SYSTEMATIC LITERATURE REVIEW 
Camilla Dahl(1), Megan Crichton (1), Julie Jenkins (2), Romina 
Nucera (2), Sophie Mahoney (1), Skye Marshall (1)
1Bond University, Gold Coast, Australia 
2Robina Hospital, Gold Coast, Australia
Background: Due to a lack of evidence regarding the dietary 
management of acute uncomplicated diverticulitis, practice 
varies for discharge nutrition recommendations, and may 
include modified dietary fibre diets, fibre supplementation, 
and/or probiotic supplementation. However, these therapies 
alone or in conjuction have not yet been sufficiently evaluated 
for the prevention of diverticulitis recurrence and impact on 
recovery;  the lack of consistency may increase patient burden, 
health care costs and decrease efficacy and adherence. 
Therefore, this systematic review aims to review the evidence 
and develop recommendations for dietary fibre modifications, 
either alone or alongside probiotics, versus any comparator 
on reoccurrence, gastrointestinal symptoms and health care 
use for adults following an episode of acute, uncomplicated 
diverticulitis.
Methods: Intervention and observational studies in any 
language were located using five electronic databases up 
until March 31st, 2017, using a combination of keywords and 
controlled vocabulary. GRADE was used to evaluate the overall 
quality of the evidence and to develop recommendations.
Results:  Three studies were included which used dietary fibre 
modifications and none used probiotic supplementation. Due 
to lack of consistent reporting, data could not be pooled. There 
was “very low” quality of evidence for using a high dietary 
fibre diet or supplements as opposed to a standard or low 
dietary fibre diet following resolution of an acute episode to 
improve reoccurrence and gastrointestinal symptoms. GRADE 
was used to develop clinical recommendations considering 
existing and generalised evidence, safety, preferences of 
stakeholders, and feasibility.
Conclusions: Health care providers should recommend a 
long-term high dietary fibre intake (meeting or exceeding the 
nationally recommended intake for gender and age) after the 
acute episode of uncomplicated diverticulitis has resolved 
(strong recommendation based on very low-quality evidence). 
Further well conducted randomised controlled trials are 
required.  
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343684839
A COLLABORATIVE APPROACH TO CARING FOR PATIENTS 
WITH JEJUNOSTOMY FEEDING TUBES: KNOWLEDGE, 
CONFIDENCE AND ATTITUDES OF NURSING STAFF 
Irene Deftereos 1, Vanessa Carter 1, Regina Muneri 1, 
Rhiannon Waites 1
Western Health, Melbourne, Australia
Background: Many Upper Gastrointestinal Surgery patients 
will have a jejunostomy (JEJ) tube inserted for feeding, in 
accordance with best practice guidelines. However, JEJ 
tubes can be complex to manage and are prone to leakage, 
blockage, pain, skin breakdown and infection, which impacts 
patient morbidity and experience. A collaborative project was 
undertaken by dietetics and nursing staff, to assess current 
nursing knowledge, confidence and attitudes regarding the 
management of JEJ tubes, in order to target education. 
Methods: 40 nurses who were working on the surgical ward 
during October 2016 were asked to participate in a 35 question 
survey. Quantitative data was analysed using percentage 
scoring for multiple choice questions regarding knowledge/
practice. Confidence/attitudes were assessed by 5 point 
Leichardt scale.
Results: The response rate was 55%. Results indicated 
varying practice regarding tube blockage and rotation. 30% 
reported they would contact the medical team as a first step 
in management of tube blockage. 40% were unsure regarding 
daily rotation. Knowledge regarding management of leakage 
varied, with 23% using gauze, 22% using silicone, 35% using 
foam, and 20% unsure. The majority responded correctly 
to questions regarding use of crushed medications, correct 
flushing techniques and tube positioning. 98% agreed/strongly 
agreed that the correct management of JEJ tubes, reducing 
tube blockage and leakage was important for patient care. 
Only 49% of staff responded as confident in their current skills 
in managing leakage and blockage. 
Conclusions: Knowledge and confidence levels indicate 
the need for practice guidelines and targeted education to 
ensure correct, consistent practice. Staff feel strongly that it is 
important to correctly manage JEJ tubes, indicating they will 
be responsive to training. The results are being used to target 
educational intervention, aiming to improve patient morbidity 
and experience.  
345613641
ROAD TO RECOVERY: NUTRITION CARE PATHWAY FOR UPPER 
GASTROINTESTINAL SURGICAL ONCOLOGY PATIENTS 
Irene Deftereos 1, Vanessa Carter 1, Jasmine Everist 1 
1Western Health, Melbourne, Australia
Background: Malnutrition is highly prevalent in Upper 
Gastrointestinal (UGI) malignancy patients, and guidelines 
recommend consistent nutrition screening and intervention. 
In 2016, Western Health Dietetics established a UGI Nutrition 
Clinic alongside UGI surgical/oncology clinics, updating the 
Nutrition Care Pathway (NCP) to address service gaps. This 
project aimed to evaluate the UGI Nutrition Clinic/NCP. 
Methods: Retrospective audit of medical records was 
conducted. Nutritional status (weight loss, Body Mass Index 
(BMI)) and dietetics intervention (time, occasions of service 
(OOS)) in patients who underwent curative UGI malignancy 
resection, 12 months pre 2016 UGI NCP implementation 
(Group 1), and 12 months post implementation (Group 2) was 
compared. 
Results: Age, BMI, gender and tumour types were similar 
in Group 1 (n=32) versus Group 2 (n=30). 100% of patients 
received inpatient dietetics postoperatively. 93% in Group 2 
received preoperative immunonutrition compared to 80% in 
Group 1. Percentage weight loss was not different, contributed 
to by low yield/missing data. 
57% in Group 2 received assessment at time of diagnosis, 
compared to 25% in Group 1. Dietitian input in radiotherapy/
chemotherapy increased from 78% to 100%. 78% of patients 
received review post neoadjuvant therapy, previously not 
provided. Feeding tube insertion intraoperatively increased 
from 30% to 80% in total gastrectomy/oesophagectomy 
patients. 
Average dietetic outpatient time preoperatively increased from 
2 minutes/4% of OOS pre implementation to 35 minutes/27% 
of OOS. Average OOS preoperatively increased from 1.7 to 
4.5. 93% received follow up within 3 weeks post discharge, 
compared to 20% pre implementation. Average time increased 
from 19 minutes/0.4 OOS to 59 minutes/1.8 OOS. Post 
implementation, 4 feeding tube related admissions were 
avoided. 
Conclusions: A UGI Nutrition Clinic and NCP significantly 
increases consistent, timely, effective nutrition care reflecting 
best practice. Determination of nutritional, quality of life and 
surgical outcomes is warranted.
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345731757
CHEMOTHERAPY… THE OVERLOOKED TREATMENT IN HEAD 
AND NECK CANCER. A REVIEW OF NUTRITION OUTCOMES. 
 
 
Den Elise1, Gilliland Sarah1, Rowan Kirsty1, McKie Emma1, 
Steer Belinda1
1Department of Nutrition and Speech Pathology, Peter 
MacCallum Cancer Centre, Melbourne, Australia
 
Background 
Common treatment for patients with oropharyngeal cancer is 
concurrent chemoradiotherapy. The systemic therapies that 
are used in combination with radiotherapy include cisplatin, 
cetuximab and carboplatin. This study aimed to explore 
the relationship between different systemic therapies and 
nutrition outcomes in patients with oropharyngeal cancer. 
Methods
A retrospective audit of patients with oropharyngeal cancer 
undergoing (chemo)radiotherapy was completed over a 
6-month period. Patients were divided into subgroups based 
on systemic therapy dose and regimen. Nutritional outcomes 
including weight loss during treatment, 4 weeks post 
treatment and hospital admissions were analysed.
Results
The audit involved forty-eight participants with oropharyngeal 
cancer, median (IQR) age 58.5 (52-68) years and 85% (n=48) 
male. Systemic therapy regimes included weekly cisplatin (CP, 
25%), high dose cisplatin delivered in weeks 1, 4 and 7 (HDCP, 
42%), weekly carboplatin (CB, 21%) and weekly cetuximab (CT, 
12%). Weight change by systemic therapy regime revealed 
those receiving CP had the largest weight loss (mean (SD) at 
both time points, during treatment (10.07 (4.36)%) and at 4 
weeks post-treatment (10.36 (5.04)%). Conversely, patients 
receiving CT alvarez.ella10@gmail.comlost the least amount 
of weight (mean (SD) both during treatment (3.66 (1.78)%) 
and at 4 weeks post-treatment (5.90 (3.32)%). There was no 
difference in weight loss during treatment between CB and 
HDCP groups. 
Fifty-two percent of participants (n =48) required inpatient 
admission during treatment. Forty-four percent  (n=25) of 
patients admitted received HDCP and 31% (n=25) received CP. 
Those requiring admission lost more weight during treatment 
(t=2.37, p=0.021) and 4 weeks post treatment (t=2.05, 
p=0.046) than those who did not require an admission.
Conclusion
This study showed a trend towards greater decline in 
nutritional outcomes for patients receiving cisplatin based 
treatment, compared to cetuximab or carboplatin. However, 
further research is needed.
345752281
NUTRITION -  A MUCH BIGGER PLAYER IN CRITICAL CARE 
THAN WE THOUGHT? 
Ra’eesa Doola 1,2; Associate Professor David J Sturgess 2, 3; 
Professor Josephine M Forbes 2
1. Mater Group, Brisbane, Australia
2. Mater Research Institute - The University of Queensland, 
Brisbane, Australia
3. Princess Alexandra Hospital, Brisbane, Australia
Background: Advanced glycation end-products (AGE) 
are glycated protein or lipid molecules acquired through 
endogenous formation and intake of exogenous sources1.  
Emerging evidence indicates that when bound to its receptor, 
RAGE, it can trigger an unbridled inflammatory response 
leading to failure of inherent control mechanisms causing 
extensive systemic and tissue inflammation which in turn is 
associated with adverse clinical outcomes in the critically ill2. 
Investigators hypothesise that nutritional formulae provision 
in critical care may contribute significant amounts of AGE to an 
existent endogenous pool and aim to quantify the AGE content 
of nutritional formulae so as to compare this to predefined low 
and high AGE diets1.
Methods: Samples of nutritional formulae were collected and 
batch analysed for AGE content using ultra performance liquid 
chromatography tandem mass spectrometry. 
Results:  Table 1: AGE content of formulae 
~Volume 
required*
CML 
(mg/d)
CEL 
(mg/d)
MG-H1 
(mg/d)
Abbott Nutrition
Glucerna 1.9L 18 11.2 63.3
 Jevity + Fibre 1.9L 14.4 2.1 6.8
Nutricia
 Diason 1.8L 9.4 20.5 179.3
 Nutrison 
Multifibre 1.8L 18.5 7.4 18.2
 Nutrison Protein 
Plus Multifibre 1.5L 27.6 9.8 31.2
Pre-defined AGE diet1 
Low NA 3.1 2 18
High NA 4.2 3.1 24.6
*Based on estimated requirement for a 75kg person at 25kcal/
kg  
With the exception of Jevity, all other nutritional formulae 
contain, at a minimum, eighty percent more AGE than that 
found in a high AGE diet.
Conclusions: Nutritional formulae contain high levels of AGE 
when compared to pre-defined dietary thresholds. Dietary 
AGE coupled with endogenous production has the potential to 
exacerbate inflammation causing cell death and organ failure. 
Further prospective studies are needed investigating the role 
dietary AGE exert on clinical outcomes in critically ill patients.
References: 
De Courten B. Am J Clin Nutr. 2016;103(6):1426-1433
Ingels C Shock. 2015;43:109-116
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345735810
MALNUTRITION PREVALENCE AND ASSOCIATED OUTCOMES
Grundy, L (1), Sandison, A (1), Osborne, J (1), Fetterplace, K (1)
1. Department of Clinical Nutrition, The Royal Melbourne 
Hospital, Melbourne, Australia
Background:  Malnutrition is highly prevalent in hospitals and 
is associated with poorer outcomes. Malnutrition screening 
has been mandatory within Australian hospitals for over 5 
years, however it receives significantly less attention compared 
to other risk outcomes such as pressure injuries and falls. The 
aims of this study were to assess compliance and accuracy of 
malnutrition screening, determine malnutrition prevalence 
and associations with length of stay (LOS), falls and pressure 
injuries. 
Methods:  A one day point prevalence audit was undertaken 
across a tertiary hospital in Melbourne. Data collection 
included demographics, malnutrition risk (Malnutrition 
Screening Tool) (MST), nursing compliance and accuracy with 
screening, and appropriate dietitian referrals.  A malnutrition 
assessment (Subjective Global Assessment) was completed 
for all patients deemed at risk, and 30 day outcome data was 
collected including LOS, falls and pressure injuries. 
Results:  Of the 306 patients included, 52% were male (n=160), 
median [IQR] age was 71 [52-80] years, BMI was 25.2 [22.3-
29.3] kg/m2 and LOS was 13 [6-27] days. Compliance with 
malnutrition screening on admission was 78% (n=239), of 
which 71% (n=170) were accurate. Only 58% (n=19) of at 
risk patients were referred to a Dietitian. The prevalence of 
malnutrition was 36% (n=109), which was greater than the 
prevalence of both falls (5.2%, n=16) and pressure injuries 
(4.6%, n=14). There was a significant difference in the 
median LOS (days) for malnourished patients (Md 17, n=109) 
compared to well-nourished patients (Md 11, n=197) (U = 
8442, z = -3.10, p=.002). Malnourished patients had a 10 fold 
increased risk of developing a pressure injury, Relative Risk [CI] 
10.8 [2.5-48] p=0.0001.
Conclusions:  The accuracy of screening and dietetic referral 
rates for at risk patients was poor. Malnutrition was associated 
with increased length of stay and pressure injuries.  Improved 
awareness of malnutrition and associated consequences is 
required.
345715854
SARCOPENIA IS ASSOCIATED WITH SEDENTARY BEHAVIOUR 
AND PHYSICAL ACTIVITY IN PEOPLE WITH MALIGNANT 
PLEURAL MESOTHELIOMA
Jeffery E1, Lee YCG2,3,4, Newton RU1,5, Lyons-Wall P6, 
McVeigh J7, Straker L8, Nguyen B9, Peddle-McIntyre C1
1Exercise Medicine Research Institute, Edith Cowan University, 
Joondalup, Australia
2Respiratory Department, Sir Charles Gairdner Hospital, 
Nedlands, Australia
3Institute of Respiratory Health, Nedlands, Australia
4School of Medicine and Pharmacology, University of Western 
Australia, Nedlands, Australia
5UQ Centre for Clinical Research, University of Queensland, 
Herston, Australia
6School of Medical and Health Sciences, Edith Cowan 
University, Joondalup, Australia
7School of Occupational Therapy and Social Work, Curtin 
University, Bentley, Australia
8School of Physiotherapy and Exercise Science, Curtin 
University, Bentley, Australia
9 Medical Oncology Department, Sir Charles Gairdner Hospital, 
Nedlands, Australia
Background: People with malignant pleural mesothelioma 
(MPM) have low levels of physical activity (PA) and often 
experience muscle wasting (sarcopenia), however, the impact 
of sarcopenia on sedentary behaviour and PA has not been 
examined. Therefore, this study aimed to investigate the 
relationship between sarcopenia, sedentary behaviour and PA 
in people with MPM.
Methods: Sarcopenia was defined as appendicular muscle 
mass <7.26 kg/m2 for men and <5.45 kg/m2 for women, as 
estimated by Dual-Energy X-Ray Absorptiometry. Sedentary 
behaviour and PA were measured using an Actigraph GT3X+ 
accelerometer, worn by participants 24 hr/day for 3 days, and 
classified as sedentary (<100 counts/minute (cpm)), light (100-
1952 cpm) or moderate and vigorous (MVPA; >1952 cpm).
Results: Twenty-four people with MPM had complete 
data available for analysis (mean±SD; age 68.3±7.5 years, 
BMI 26.3±3.8 kg/m2, 20 male). Twelve people (50%) were 
sarcopenic. Those with sarcopenia, compared to those without 
sarcopenia, spent a significantly higher proportion of time 
in sedentary behavior (71.8±10.2% vs. 62.6±9.4%; p=0.031), 
and a lower proportion of time in light activity (26.9±9.9% vs. 
35.5±9.4%; p=0.040).  The proportion of time spent in MVPA 
was low and did not differ between the two groups (median 
[IQR]; 0.7 [0.3-2.0]% vs. 1.6 [0.4-3.2]%, p=0.299). Those with 
sarcopenia had fewer bouts of light activity of 5 to <10 min 
and 10 to <20 min duration (9.6±5.7 vs. 14.7±5.4; p=0.034 and 
2.2±2.2 vs. 4.4±1.9; p=0.017, respectively).
Conclusions: In this study, people with MPM who had 
sarcopenia were significantly more sedentary and spent 
less time in light activity, particularly at longer durations. 
This raises the possibility that sarcopenia contributes to an 
impaired ability to participate in PA. Nutrition, exercise and 
pharmacological interventions that address sarcopenia could 
be effective for increasing PA levels in this population.
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345729212
THE EFFECT OF POLYPHENOLS ON CARDIOVASCULAR RISK 
FACTORS IN HAEMODIALYSIS: A SYSTEMATIC REVIEW AND 
META-ANALYSIS
Jaimon Kelly,1 Skye Marshall,1 Stacey Nakos,2 Catherine 
Itsiopoulous,2 Wolfgang Marx2
1 Bond Univeristy, Gold Coast, Australia
2 La Trobe University, Melbourne, Australia
Background: End-stage kidney disease is a major health burden 
worldwide and is a strong risk factor for sudden cardiac death. 
Polyphenol supplementation has been suggested to reduce 
cardiovascular risk factors in haemodialysis patients. The aim 
of this systematic review was to pool and evaluate the current 
evidence for polyphenol interventions for cardiovascular risk 
reduction in haemodialysis patients. 
Methods: The Cochrane Library, MEDLINE (vis Scopus), 
Embase, and CINAHL were searched for double-blind placebo-
controlled randomised trials up until 29 June 2017. Phenol-
Explorer 3.6 database was used to inform known polyphenol-
rich interventions.  Treatment effect was quantified by meta-
analysis for measures of lipid profile, inflammation, oxidative 
stress, and blood pressure. Risk of bias was assessed using 
the Cochrane Collaboration Risk of Bias tool and quality of the 
body of evidence assessed by the GRADE methodology.
Results: Twelve studies were included which utilised the 
polyphenol-rich supplements soy, cocoa, pomegranate, 
grape, and turmeric in powder or juice form. Risk of bias 
across studies was mostly low; though randomisation and 
allocation was poorly described in most studies. Polyphenol 
interventions significantly improved diastolic blood pressure 
(MD -5.62mmHg [95% CI -8.47, -2.78]; I2=2%; p=0.0001; n=4 
studies; n=245 participants; GRADE: moderate), triglyceride 
levels (MD -26.52mg/dL [95% CI -47.22, -5.83]; I2=57%; 
p=0.01; n=4 studies; n=191 participants; GRADE: very low), 
and oxidative stress (myeloperoxidase) (SMD -90.1 [95% 
CI -135.8, -44.4]; I2=0%; p=0.0001; n=2 studies; n=126 
participants; GRADE: high). Improvements in other measures 
of haemodynamics and lipid profiles were significant with 
large effect sizes in sub-samples with hypertension and 
hypercholesterolaemia respectively (not pooled).
Conclusions: The results suggest polyphenol-rich 
supplementation may improve cardiovascular risk markers 
in haemodialysis patients, especially those with existing 
cardiovascular disease. Further studies of sufficient 
duration are required to establish efficacy and allow for 
recommendation of particular polyphenol types and dosages.
345728285
MEASURED ENERGY EXPENDITURE IN CRITICALLY ILL BURN 
PATIENTS CORRELATES WITH TIME POST-INJURY BUT NOT 
BURN SIZE
King S1, Leung J2, Ihle J3, Ridley E4, Paul E5, Cleland H2
1 Nutrition Department, Alfred Health, Melbourne, Australia
2 Victorian Adult Burns Service, Alfred Health, Melbourne, 
Australia
3 Intensive Care Unit, Alfred Health, Melbourne, Australia
4 ANZIC-RC,Department of Epidemiology and Preventive 
Medicine, Monash University, Melbourne, Australia
5 Department of Epidemiology and Preventive Medicine, 
Monash University, Melbourne, Australia
Background: Clinical guidelines for both critical illness and 
burn injury advocate the measurement of energy expenditure 
(EE) by indirect calorimetry (IC) to guide energy provision; 
however prediction equations are still widely used where IC 
is unavailable or not feasible. Aims: (1) to investigate how 
measured EE (mEE) changes over time in burn injury; (2) to 
compare mEE with predicted energy requirements (predER).
Methods: Data were retrospectively analysed on burn patients 
admitted to an Intensive Care Unit (ICU) between 2013-2015, 
in whom IC was performed to measure EE (Quark, Cosmed). 
mEE was divided by predicted basal metabolic rate (Schofield 
equation) to calculate degree of EE elevation (mEE%predBMR). 
predER was calculated using Schofield, Harris-Benedict, Ireton-
Jones and Curreri equations, adjusted using published stress 
factors for burn injury. Bland-Altman analysis compared bias 
between mEE and predER. Spearman’s correlation coefficients 
assessed predictors of mEE%predBMR and mEE expressed as 
kJ/kg (mEEkJ/kg) and correlation between bias and day post-
burn.
Results: Twnety-nine burn patients (median[IQR] age 46[28-
61]years, %TBSA burn 37[18-46]%) underwent IC on 1-4 
occasions (46 measurements total, up to day 38). Mean±SD 
mEE was 9752±2089kJ/day; or 130±35kJ/kg/day. Mean±SD 
mEE%predBMR was 142±33%. Both mEE (r=0.42, p=0.004) and 
mEE%predBMR (r= 0.35, p=0.016), but not mEEkJ/kg (r=0.28, 
p=0.06) correlated positively with day post-burn. %TBSA did 
not correlate with mEE, mEE%predBMR or mEEkJ/kg.  Bland-
Altman Analysis displayed substantial variability between 
mEE and predER, with clinically important overestimation for 
three equations and wide 95% limits of agreement (LOA) for 
all equations (Table). Overestimation of EE was more marked 
early post-burn whilst underestimation was observed from day 
7.  
Prediction 
Equation
Mean bias(kJ/
day) (predER – 
mEE) 
95% LOA (kJ/
day)
Correlation 
between bias 
and day post-
burn 
Schofield -54±2373 -4802 to 4692 r=0.33, p=0.03
Harris-
Benedict 
1728±2784 -3839 to 7296 r=0.30, p=0.04
Ireton-
Jones 
1276±2092 -2907 to 5460 r=0.48, p=0.001
Curreri 4476±3402 -2327 to 11280 r=0.18, p=0.24
 Conclusions: There are clinically important discrepancies 
between measured energy expenditure and prediction 
equations in critically ill burn patients. The use of IC in burn 
injury may minimise the risk of over- and underfeeding 
compared to prediction equations. 
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DOES BARIATRIC SURGERY CAUSE MICRONUTRIENT 
DEFICIENCY?: A SYSTEMATIC REVIEW
Carrie-Anne Lewis 1, 2, Dr. Ingrid Hickman 2, 3 , Dr. Susan de 
Jersey 1, 4, Emma Osland 1, 2
1 Royal Brisbane and Women’s Hospital, Brisbane, Australia
2 University of Queensland, Brisbane, Australia
3 Princess Alexandra Hospital, Brisbane, Australia
4 Queensland University of Technology, Brisbane, Australia
Background: The restrictive and/or malabsorptive nature 
of bariatric surgery increases the risk for micronutrient 
deficiencies.  This systematic review aimed to identify the 
evidence for vitamin A, B1, C or E deficiencies associated with 
bariatric surgery.  
Methods: Medline, CINHAL, Embase were searched for 
articles that reported on micronutirnet deficiency rates before 
and up to 12 months after adjustable gastric band (AGB), 
sleeve gastrectomy (SG) and/or gastric bypass (GB).  Data 
was extracted and analysed independently by two authors. 
PRISMA and MOOSE frameworks were utilised with NHMRC 
evidence hierarchy and the American Dietetic Association 
(ADA) assessment of bias tool were used to assess the quality 
of articles. 
Results: Nine eligible studies investigating SG (n=8) and AGB 
(n=1) all were level IV studies either neutral or negative 
quality. Of the 16 eligible articles in GB, n=15 were level IV 
studies, either neutral or negative quality and n=1 was a level 
II study, positive quality. No significant risk of vitamin A, B1, C 
or E deficiency was found after AGB.  The literature suggests 
a decreased risk of vitamin C deficiency and increased risk for 
vitmian B1 deficiency after SG and GB.  For vitamin A, after GB 
there appears to be an increased risk of deficiency at 6 months 
postoperatively, which improves at 12 months. No consistent 
results were found for vitamin A in SG or vitamin E in SG or 
GB.  Limitations to all studies included no monitoring for 
inflammation, limited information on micronutrient intake and 
surgical technique and inconsistent definitions of deficiency.  
Conclusions:  This literature suggests that SG and GB may 
increase the risk of vitmian B1 deficiency and GB may increase 
the risk of vitamin A deficiency.  Future research is needed to 
investigate confounders to serum vitamin A, B1, C and E.
345720847
A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE 
CRITERION VALIDITY OF NUTRITION ASESSMENT TOOLS 
FOR DIAGNOSING PROTEIN-ENERGY MALNUTRITION IN THE 
OLDER COMMUNITY SETTING 
Skye Marshall1, Dana Craven2, Jaimon Kelly1, Elizabeth 
Isenring3
1 Bond University, Robina, Australia
2 University of the Sunshine Coast, Sippy Downs, Australia
Background: Accurate diagnosis is a key step in managing 
protein-energy malnutrition. This review seeks to determine 
the criterion (concurrent and predictive) validity and reliability 
of nutrition assessment tools in making a diagnosis of protein-
energy malnutrition in community-living older adults.
Methods: A systematic literature review was undertaken using 
six electronic databases in September 2016. Studies in any 
language were included which measured malnutrition via a 
nutrition assessment tool in adults ≥65 years living in their 
own homes. Data relating to the predictive validity of tools 
were analysed via meta-analyses. GRADE was used to evaluate 
the body of evidence.
Results: There were 6,412 records identified, of which eight 
papers were included. Two studies evaluated the concurrent 
validity of the Mini Nutritional Assessment (MNA) and 
Subjective Global Assessment (SGA) and six evaluated the 
predictive validity of the MNA. The quality of the body of 
evidence for the concurrent validity of both the MNA and 
SGA was very low. The quality of the body of evidence for the 
predictive validity of the MNA in detecting risk of death was 
moderate (RR: 1.92 [95%CI: 1.55-2.39]; P<0.00001; n=2,013 
participants; n=4 studies; I2: 0%). The quality of the body of 
evidence for the predictive validity of the MNA in detecting 
risk of poor physical function was very low (SMD: 1.02 [95%CI: 
0.24-1.80]; P=0.01; n=4,046 participants; n=3 studies; I2:89%).
Conclusions: Due to the small number of studies identified and 
no evaluation of the predictive validity of tools other than the 
MNA, there is insufficient evidence to recommend a particular 
nutrition assessment tool for diagnosing protein-energy 
malnutrition in older adults in the community setting. High 
quality diagnostic accuracy studies are needed for all nutrition 
assessment tools used in older community samples, including 
measuring of health outcomes subsequent to nutrition 
assessment by the SGA and PG-SGA.
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THE EFFECT OF RESVERATROL ON COGNITIVE PERFORMANCE: 
A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS. 
Wolfgang Marx EG1, Jaimon Kelly EG2, Skye Marshall EG2, 
Jennifer Cutajar EG1, Brigitte Annois EG1, Andrew Pipingas 
EG3, Audrey Tierney EG1, Catherine Itsiopoulos EG1
1School of Allied Health, La Trobe University, Australia
2Faculty of Health Sciences and Medicine, Bond University, 
Australia 
3Centre for Human Psychopharmacology, Swinburne University 
of Technology, Australia
Background: Due to the increasing burden of age-related 
cognitive decline, interventions that can improve cognitive 
performance are of interest. Resveratrol, a plant derived 
polyphenol, has been reported to improve cognitive 
performance in animal models and has recently been 
investigated in several clinical trials. The aim of this systematic 
review was to evaluate clinical trial data regarding the effect of 
resveratrol on cognitive performance. 
Methods: In accordance with PRISMA guidelines, a systematic 
literature review and meta-analysis was conducted using the 
following databases: MEDLINE, CINAHL, Cochrane, EMBASE 
and Proquest. Studies included in this review stipulated that 
the independent variable was resveratrol and used outcome 
measures of cognitive performance. A meta-analysis was 
conducted to determine treatment effect on the following 
cognitive domains and mental processes: processing speed, 
number facility, mood, and memory. Risk of bias was assessed 
using the Cochrane Collaboration Risk of Bias tool; and quality 
of the body of evidence assessed by GRADE.
Results: Ten clinical trials were included. Three studies 
reported resveratrol to significantly improve some measures 
of cognitive performance, two reported mixed findings, and 
five reported no effect. When data was pooled, resveratrol 
significantly improved delayed recognition, a measure of 
working memory (SMD 0.39 [95% CI 0.08, 0.70]; I2=0%; 
p=0.01; n=3 studies; n=166 participants; GRADE level: 
moderate) and negative mood (SMD -0.18 [95% CI -0.31, 
-0.05]; I2=0%; p=0.006; n=3 studies; n=163 participants; 
GRADE level: moderate). Included studies generally had 
low risk of bias and study outcomes were of moderate 
or high quality. There was considerable heterogeneity in 
the methodology of the included studies regarding the 
intervention length, and participant age and disease status
Conclusion: The results of this systematic review indicate 
that resveratrol might improve select measures of cognitive 
performance; however, the current literature is inconsistent. 
Future studies are recommended to focus on long-term 
supplementation and adjustment for existing limitations such 
as dietary polyphenol intake. 
345273811
A MODEL FOR ESTABLISHMENT OF A DIETITIAN LED 
GASTROENTEROLOGY CLINIC IN A LARGE TERTIARY HOSPITAL 
IN AUSTRALIA 
Rumbidzai Mutsekwa , Anthony Whitfield, Russell Canavan, 
Alan Spencer, Rebecca Angus
1 Gold Coast Hospital and Health Service , Gold Coast,  
Australia
Background:Models of care utilizing allied health practitioners 
working in an extended scope of practice (ESP) as the first 
point of contact for patients have proven effective in managing 
waitlist demand in a range of specialities.  Key features in the 
establishment of a dietitian led gastroenterology clinic (DLGC) 
are described. 
Methods: A business concept was developed for a DLGC 
to provide care for a select cohort of gastroenterology 
patients. Development of eligibility criteria was based on the 
Queensland Gastroenterology Clinical Prioritization Criteria 
2016. An audit of waitlists was performed, and eligible patients 
offered an appointment in the DLGC. After clearance of the 
initial backlog, ongoing triaging and reallocation to the DLGC 
was conducted by the GE consultant.
Results:The eligibility criteria developed for the DLGC 
included category 2, <50 years of age with dyspepsia/heart 
burn, reflux, abdominal pain, constipation, diarrhoea, or 
altered bowel habits and no alarm symptoms. 346 new and 
272 review patients were seen over the initial 12 months, 
representing 82% of category 2 and 29% of all new general 
gastroenterology patients. The dietitian organised screening 
pathology under ESP. Patients were provided with dietary and 
lifestyle management strategies and to date, 68% (234/346) 
of patients have been discharged to the care of their GP with 
satisfactory resolution of  symptoms. 28 patients (8%) were 
assessed as requiring medical review and were triaged back to 
the gastroenterologist. Enablers for successful establishment 
included alignment with broader hospital and health service 
strategic objectives, strong support from management, 
positive relationships between stakeholders and an opt-out 
process.
Conclusions: A model for the formation of a DLGC, along 
with enablers for successful implementation has been 
established. This may be used elsewhere to address outpatient 
gastroenterology service demand pressures.
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RETROSPECTIVE EVALUATION OF A DIETITIAN LED 
GASTROENTEROLOGY CLINIC AND ITS IMPACT ON A TERTIARY 
GASTROENTEROLOGY SERVICE IN SOUTHEAST QUEENSLAND
Rumbidzai Mutsekwa , Anthony Whitfield, Russell Canavan, 
Alan Spencer, Rebecca Angus
1 Gold Coast Hospital and Health Service , Gold Coast,  
Australia
Background: New models of care are needed to meet growing 
demand for gastroenterology specialist services and reduce 
unacceptably long wait lists, within budgetary constraints. 
The dietitian-led gastroenterology clinic (DLGC) was one of a 
number of initiatives undertaken within our health service to 
address these concerns. 
Methods: The service was evaluated through a mixed methods 
approach, comprising an audit of gastroenterology waitlists 
pre- and post-DLGC implementation, calculation of estimated 
costs for service provision to eligible patients via each model, 
chart audit of patient characteristics and a survey of patient 
satisfaction with care received.
Results: Pre-post comparison was conducted against a 
background of rising service demand, with a 25% increase in 
referrals over the study period. For DLGC–eligible patients, 
the average wait for service decreased from 160 to 33 
days, and the percentage of patients in breach of clinically 
recommended wait times reduced from 74% (76/103, median 
breach days = 92) to zero.  The flow on effect of medical 
specialist availability to see more complex and urgent patients 
was reflected in the reduction in wait time for non-DLGC 
eligible, general gastroenterology patients from 166 to 70 
days. Service provision via the DLGC was costed at less than 
60% of average gastroenterologist consultation, based on staff 
salaries. Additional savings may have been realised from a 
reduction in the number of colonoscopies and gastroscopies 
(estimated $1200-1900 per procedure), for which most of the 
346 new patients seen in the DLGC were originally referred. 
Patient surveys indicated a high level of satisfaction with the 
service received in the DLGC.
Conclusions: This model of care effectively assisted in the 
management of gastroenterology waitlists. It improved 
patient access to care whilst displaying significant cost saving 
potential. 
345617107
ASSESSING THE AGREEMENT BETWEEN PATIENTS AND 
DIETITIAN, AND THE USABILITY OF THE PG-SGA AND PT-
GLOBAL APP IN THE AUSTRALIAN ONCOLOGY SETTING
Naranjo, A.1 Abbott, J. 2 Teleni, L. 1 Ottery, F3. Jager-
Wittenaar, H4. Isenring, E. 1  
1 Bond University, Robina, 4226, Australia
2 Gold Coast University Hospital, Southport, 4215, Australia
3 Ottery & Associates, LCC, Vernon Hills, 60061, United States 
of America
4 Hanze University of Applied Sciences, Groningen, 9714 CE, 
The Netherlands
Background: In Australia, dietitians have been trained to 
administer the PG-SGA in its entirety. In 2014, the electronic 
version of PG-SGA (Pt-Global app) was released. The mode 
in which this tool is administered varies internationally and 
can differ within countries and settings. The aim of this study 
was to evaluate the agreement between patient versus 
dietitian-administered patient-generated sections of PG-SGA 
and PtGlobal app tools, and to assess the usability, timing and 
assistance required to complete the patient-generated section 
of both tools.
Methods: Cross-sectional study of 200 consecutive adult 
patients receiving ambulatory anticancer therapy at an 
Australian tertiary hospital. Patients were randomised into 
four groups: two using the PG-SGA and two the Pt-Global 
app. Agreement between patient and dietitian-administered 
PG-SGA short form (SF) scores, nutrition impact symptoms 
(NIS) scores and Global Ratings for both tools were tested. The 
usability of, time and assistance required to complete each 
tool was also investigated. 
Results: Irrespective of the tool, there was excellent 
agreement between patients and dietitian-administered  
scores for the PG-SGA SF (ICC>0.89), NIS scores (ICC>0.079) 
and Global Rating (K>0.82). Median time to completion of the 
SF was significantly longer in the patient-administered versus 
dietitian-administered SF in both tools. Patient-generated 
section of both tools were completed in <4 min. Assistance to 
complete the SF when patient-administered was required by 
46.5% Pt-Global app versus 31.3% of PG-SGA participants. 
Conclusion: Patient versus dietitian-administration scores and 
global ratings of both the PG-SGA and Pt-Global app have 
excellent agreement with only marginal differences in time to 
complete, suggesting that either can be used interchangeably 
in practice.The feasibility of implementing the patient-
generated component for routine nutrition screening should 
be assessed given the proportion of patients that required 
assistance.
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PANCREATIC EXOCRINE INSUFFICIENCY AND NUTRITIONAL 
OUTCOMES AFTER PANCREATOC RESECTION. 
Yue Xian (Selena) OOI 1, Karen PERCY 1, Christopher NHAM 
2,3, Fiona SIMPSON 1, Gwen HICKEY 1, Jasminder SAMRA 2,3, 
Anubhav MITTAL 2,3
1Nutrition Services, Royal North Shore Hospital, St Leonards, 
Australia 
2Upper Gastrointestinal Surgical Unit, Royal North Shore 
Hospital, St Leonards, Australia
3Sydney Medical School, The University of Sydney, Sydney, 
Australia
Background: 
Pancreatic resection (PR) is associated with the development 
of pancreatic exocrine insufficiency (PEI) and its sequelae 
including malnutrition, fat-soluble vitamin deficiency, and 
osteoporosis. A multidisciplinary clinic was established at our 
institution in November 2016 for the purpose of diagnosis 
and management of PEI through standardised nutritional 
assessment and initiation of pancreatic enzyme replacement 
therapy (PERT). In this study, we aimed to define the rate of 
PEI and nutritional abnormalities in an Australian cohort of 
patients who underwent PR. 
Methods: 
Data from all patients who attended our clinic for PEI and 
nutritional assessment were included for analysis as part 
of a prospective observational study. Clinical data were 
prospectively obtained from all patients as part of a proforma 
assessment of diet, PERT compliance, anthropomorphic 
parameters, and measures of frailty and sarcopoenia. 
Laboratory data were also prospectively collected including 
assays for micronutrients, faecal elastase-1, HbA1c, and bone 
mineral density scans. 
Results: 
Seventeen patients were included, fifteen of whom had 
laboratory and bone results available for analysis. Eleven 
patients had a faecal elastase-1 <100ug/g faeces (severe PEI), 
and ten patients had at least one micronutrient deficiency. 
Five patients had osteoporosis, and three patients had a 
HbA1c >7%, mandating referral to an endocrinologist. Nine of 
seventeen patients were assessed as malnourished. 
Conclusions: 
Pancreatic exocrine insufficiency, micronutrient deficiency, 
and osteoporosis are highly prevalent sequelae of pancreatic 
resection. A dedicated multidisciplinary team approach in the 
management of PEI and nutrition is essential for the holistic 
management of these patients. 
345691174
THE IMPACT OF PANCREATIC RESECTION ON QUALITY OF LIFE 
– AN OBSERVATIONAL COHORT STUDY
Christopher B Nahm [1,2], Yuexian Ooi [3], Karen Percy [3], 
Fiona Simpson [3], Gwen Hickey [3], Jaswinder Samra [1,2], 
Anubhav Mittal [1,2]
1 Upper Gastrointestinal Surgical Unit, Royal North Shore 
Hospital, Sydney, Australia
2 Sydney Medical School, The University of Sydney, Sydney, 
Australia
3 Nutrition Services, Royal North Shore Hospital, Sydney, 
Australia
Background: 
Patients undergoing pancreatic resection endure long 
term morbidity due to the effects of pancreatic exocrine 
insufficiency (PEI), altered gut motility and pancreaticobiliary 
and gastroenteric reconstruction. In this prospective 
observational study, we aimed to define the impacts on quality 
of life in patients who underwent pancreatic resection. 
Methods: 
All patients who underwent pancreas resection at our 
institution from November 2016 have been referred to our 
multidisciplinary PEI clinic after surgery, but not all have 
attended. Data from patients who attended this clinic were 
included for analysis. All patients completed a questionnaire 
prior to their first clinic appointment, namely QLQ-C30 – a 
validated patient-based quality of life instrument comprising 
30 items that scale physical, role, cognitive, social and 
emotional function along with severity of fatigue, pain, nausea 
and vomiting. Scores were compared with published data on 
age-matched healthy controls. 
Results: 
Seventeen patients have so far been reviewed at our clinic 
and included in this interim analysis. No significant difference 
was found in overall quality of life (p=0.55), physical (p=0.10), 
emotional (p=0.54), and social functioning (p=0.17), pain 
(p=0.61), and dyspnoea (p=0.38) scores compared with 
healthy controls. The following parameters were found to 
be significantly worse in this cohort than healthy controls 
(p<0.05): role functioning, cognitive functioning, fatigue, 
insomnia, appetite loss, constipation, and diarrhoea. 
Conclusions: Whilst patients who have had pancreatic 
resection report similar overall quality of life outcomes to 
healthy controls, specific parameters particularly relating to 
gastrointestinal function are reported as significantly worse. 
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345759959
PRE-OPERATIVE MALNUTRITION IS A PREDICTOR OF POST-
OPERATIVE OUTCOMES IN PERITONECTOMY SURGERY 
 Helen Dragicevich 1, Claire Lewis 2, Caila Rothwell 2, David 
L.Morris 3
1 Nutrition and Dietetics, St George Hospital, Sydney, Australia
2 Faculty of Science, Medicine and Health, University of 
Wollongong, Wollongong, Australia
3 Hepatobiliary and Surgical Oncology Unit, Department of 
Surgery, St George Hospital, University of New South Wales, 
Sydney, Australia
Background: Malnutrition is associated with increased risk of 
post-operative complications, morbidity and length of stay 
(LOS) in patients undergoing surgery for abdominopelvic 
malignancy. There are few studies that explore perioperative 
nutrition status in patients undergoing Peritonectomy 
surgery for gastrointestinal or gynecological peritoneal 
surface malignancy (PSM). This study aimed to determine 
if preoperative malnutrition, assessed using the Subjective 
Global Assessment (SGA), was associated with post-operative 
morbidity or LOS in patients undergoing Peritonectomy 
surgery.
Methods: A retrospective analysis of prospective data collected 
for a cohort of patients who underwent Peritonectomy surgery 
from February 2016 until March 2017. Anthropometry, SGA 
and handgrip strength (HGS) were collected pre-operatively. 
Thirty day post-operative outcomes were graded according 
to Clavien-Dindo, major morbidity included grade 3 or 4 
complications. 
Results: SGA scores and post-operative data was available for 
102 patients (mean age= 55 years), HGS was available for 71 
patients. The median peritoneal cancer index (PCI) indicating 
PSM spread and severity was 14 (IQR 6-29.25) and the median 
LOS was 17 days (IQR 12.5- 27).
Pre-operative prevalence of malnutrition was 32%, weight 
loss was reported by 34% of patients and 53% of patients had 
reduced HGS on at least one hand. Pre-operative weight was 
similar in well-nourished and malnourished patients; however 
a higher proportion of malnourished patients (46%) had 
symptoms of ascites or small bowel obstruction compared to 
well-nourished patients (17%) (2=9.0, P=0.03).
PCI was higher in malnourished patients (17, IQR 10-32) 
compared to well-nourished patients (13, IQR 5.5-27.5) 
(P=0.15). Major morbidity rates were higher in malnourished 
patients (49% vs 33%) however this did not reach statistical 
significance (2 =2.17, P=0.14). Malnourished patients 
experienced significantly longer LOS (26 days (IQR 16.25-31.5) 
vs 15 days (IQR 12-23) (P=0.002)). 
Conclusions: Malnutrition is prevalent in patients undergoing 
Peritonectomy surgery and is associated with longer hospital 
LOS. A higher symptom burden and trends toward higher 
rates of major morbidity were also seen in malnourished 
patients. Collaborative prospective research into improving 
patient outcomes through perioperative nutritional support is 
warranted.
344826182
CHILDHOOD OBESITY:AN EMERGING CHALLENGE IN INDIA
 Shankar B, Subbarayan A, Sreedharan L
Apollo Hospitals, Chennai, India
Apollo Cheldrens Hospital , Chennai, India
Apollo Cheldrens Hospital , Chennai, India    
Background: Childhood obesity is a global phenomenon 
affecting all socio economic groups, irrespective of age, sex or 
ethnicity. 
 Objective: The aim is to analyse the dietary pattern and food 
behaviour in children with obesity.
 Method: A prospective study was conducted from January 
-December 2016 in 95 children with Body mass index > 95th 
percentile attending the outpatient department. Demographic 
data, 24 hour diet recall and food frequency was recorded. 
SPSS 20 used to investigate the association between eating 
patterns and obesity.
Result: Children (45 boys & 50 girls) from the age group of 
three to seventeen years were included. Dietary assessment 
reveals, 50.5% (n= 48) children consumed excess calories, 
21% (n = 20) consumed the actual requirement and 28.4% 
(n= 27) were taking lesser calories than their recommended 
dietary allowances (RDA). Protein requirements were met in 
58.9 % (n=56) children, 10.5% (n=10) had excess protein and 
30.5 % (n=29) consumed less protein. 61% (n=58) children 
consumed excess fat, 22% (n=21) met their RDA and 16.8% 
(n= 16) consumed fat lesser than their requirement. Obesity 
was significantly higher in 10-15 years age group. In this group, 
females consumed additional calories than their counterparts. 
The sex difference in food habits were found to be significant 
(P<0.05) with root of obesity on the basis of food habits in this 
age group.
Conclusion: The study reveals that not all obese children 
consume excess calories and fat. There might be other factors 
like reduction in daily exercise, psychological factors and 
genetics, contributing to obesity which needs to be evaluated. 
There are significant variations in the amount of calorie, 
protein and fat consumed in children with obesity. Hence 
each individual should have a detailed dietary assessment and 
individualised diet plan should be prescribed.
Key words: Childhood obesity, Dietary assessment 
Conflict of Interest : None
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345067569
DOES HYPOCALORIC FEEDING IMPACT THE OUTCOME OF 
CRITICALLY ILL WITH INCREASED BMI?
IN Shankar B EG1, Vasumathi EG2, Rajalakshmi EG1, Daphnee 
D K,Ramakrishnan N EG1,3
1 Apollo Hospitals Chennai
2 Apollo Hospitals Chennai
3 Apollo Hospitals Chennai
4 Apollo Hospitals Chennai TRODUCTION 
In modern critical care, the paradigm of therapeutic nutrition 
is replacing traditional support in nutrition and outcome 
research in obese critically ill patients suggests a link 
between hypocaloric feeding and mortality. This study aims 
to investigate the relationship between hypocaloric feeding 
and early weaning and mortality of critically ill patient with 
increased Body Mass Index (BMI). 
METHODS 
A prospective observational study was conducted in a multi-
centric critical care unit (CCU) in a tertiary care hospital from 
January to December 2014. The sample was limited to patients 
who were in CCU for at least 3 days on enteral feeding. Data 
including demographics, BMI, baseline nutritional status 
using subjective global assessment, severity of illness (i.e., 
Acute Physiology and Chronic Health Evaluation (APACHE II) 
score), nutrition delivery and clinical outcomes were recorded. 
Statistical analysis using fisher’s exact test, chi square test, and 
Pearson correlation were performed using SPSS 11.0 version. 
RESULTS 
Out of 136 patients, comprising of 70.5% males and 29.5% 
females, aged 57.6±14.8y were classified as 53% overweight, 
44% obese, and 3% morbidly obese according to BMI. On 
admission, the mean Glasgow Coma Scale and APACHE II 
score were 9±4.943, 22±8.46 respectively. Medical diagnostic 
classification revealed 29% had respiratory failure, 9% renal, 
10% cardiac, 10% sepsis, 5% sleep apnea and 37% others. 
The mean energy and protein delivered were 1223±273 
and 50.5±13.42 respectively, derived a positive correlation 
with average CCU (10.5±7.52) and hospital length of stay 
(16.9±11.85), which was statistically significant (p < 0.005). 
Average nutrition delivery had a strong positive correlation 
with length of mechanical ventilation (p<0.05), stating the 
impact of hypocaloric feeding on early weaning process. 
CONCLUSION 
Hypocaloric regimens can be considered in over-weight and 
obese critically-ill patients, as it improves clinical outcome like 
length of stay and ventilation-free days.
345711028
NUTRITIONAL ASSESSMENT AND SUPPORT IN PAEDIATRIC 
CANCER PATIENTS UNDERGOING CHEMOTHERAPY
Shankar B, Silviasargunam C, Revathiraj²,  Rajeswari A
1 Apollo Hospitals, Chennai, India 
2 Apollo Cancer Institute, Chennai, India
3 Apollo Cancer Institute, Chennai, India
 
Background: To prevent malnutrition during cancer treatment, 
early identification and goal-directed intervention is essential. 
We aimed to study the effect of oral nutritional support (ONS) 
in improving the nutritional status of children with cancer.
Methods: A prospective observational study was conducted in 
a cancer hospital; children between 1–16 years were included. 
Patient’s demographics, baseline nutritional status, mid arm 
circumference (MAC), height for age, weight for height (W/H), 
body mass index for age (BMI/A),nutritional delivery and 
outcomes were recorded. Nutritional assessment was done 
using paediatric subjective global assessment (PSGNA) and 
screening tool for childhood cancer (SCAN).ONS was given for 
all the patients from the first chemotherapy cycle. Data were 
analyzed using SPSS version 20.0.
Results and Discussion:  59 patients, (39 boys and 23 girls) with 
mean age of 7.4 ± 3.6 yrs were recruited. PSGNA identified 
40.7% patients as malnourished, 88.1% were malnourished 
in SCAN. The average calorie and protein prescription were 
1672 ± 590, 29.7 ± 14.1 respectively. There was a significant 
improvement in calorie and protein intake between first 
admission (976 ± 344, 21.8 ± 8.10) and second admission 
(1158 ± 230, 26 ± 6.26) (p=0.000). Nutritional markers like 
BMI (16.1 ± 3.64 versus 16.0 ± 3.7), MAC (17.5 ± 3.93 versus 
18.5 ± 4.15) were considerably improved and significant 
improvement in nutritional status noted SCAN (p=0.000) and 
PSGNA (p=0.001). MAC had a significant negative correlation 
with length of stay (LOS) (p=0.001). Nutritional status assessed 
by PSGNA had a negative influence on LOS (p=0.003) and was 
found to be superior to SCAN.
Conclusion: ONS is an effective and non – invasive solution 
to malnutrition.ONS can improve the nutritional status of 
children undergoing chemotherapy if initiated early.
Key words: Nutritional assessment, Nutritional support.
37
AuSPEN 2017 Conference
329981024
CLINICAL BENEFITS OF EARLY AND EXTENDED NUTRITIONAL 
INTERVENTION IN OLDER PATIENTS DISCHARGED FROM 
ACUTE CARE- A RANDOMIZED CLINICAL TRIAL
Yogesh Sharma1, Campbell Thompson2, Billingsley kaambwa3, 
Rashmi Shahi4, Paul Hakendorf5, Michelle Miller6
1 Flinders Medical Centre and Flinders University, Adelaide, 
Australia
2 University of Adelaide, Adelaide, Australia
3 Flinders University, Adelaide, Australia
4 Monash University, Melbourne, Australia
5 Flinders Medical Centre, Adelaide, Australia
6 Flinders University, Adelaide, Australia
Background. The benefit of early provision of a nutrition 
intervention and its continuation post-discharge in older 
hospitalized patients is unclear. This study examined the 
efficacy of such an intervention on nutritional and clinical 
outcomes in older patients discharged from acute care.
Methods. In this randomized controlled trial, 148 
malnourished patients were randomized to receive either a 
nutrition intervention or usual care. Intervention included 
an individualized nutrition care plan plus a two month post-
discharge telehealth follow-up whereas control patients 
received dietetic intervention only upon referral by their 
clinicians. Nutrition status was determined by the Patient 
Generated Subjective Global Assessment (PG-SGA) tool and 
quality of life by using European Quality of Life Questionnaire 
(EQ-5D 5L). Clinical outcomes included changes in length of 
hospital stay, complications during hospitalization, Quality of 
life, mortality and re-admission rate.
Results. Fifty-four males and 94 females (mean age, 81.8 years) 
were included. Both groups improved their nutritional status 
from baseline with no significant between group difference 
noted in PG-SGA scores at three month follow-up 6.9 (95% 
CI 5.6 to 8.3) vs 5.8 (95% CI 4.8 to 6.9), (P=0.09), in control 
and intervention groups respectively. Median total length of 
hospital stay was 6 days shorter in the intervention group (11.4 
(IQR 16.6) vs 5.4 (IQR 8.1), (P=0.01). There was no significant 
difference in complication rate during hospital stay, Quality of 
life and mortality at 3-months or readmission rate at 1, 3 or 6 
months following hospital discharge.
 Conclusion. In older malnourished inpatients, an early and 
extended nutrition intervention showed a trend towards 
improved nutrition status and significantly reduced length 
of hospital stay. Provision of such an intervention could 
be beneficial to improve quality of care and may reap rich 
monetary benefits to hospitals.
345729331
IMPROVING NUTRITION CANCER CARE OUTCOMES - FIndings 
FROM A state-wide benchmarking pilot STUDY
Rebecca McIntosh, Natalie Simmance
St Vincent’s Hospital, Melbourne, Australia
Background
Malnutrition is common in patients receiving cancer treatment 
and is associated with increased morbidity, mortality and 
healthcare costs. A 2012 study showed variation in nutrition 
care for malnourished patients within Victorian Cancer 
Services. A ‘Malnutrition Governance Toolkit’ was created in 
2014 with the aim of supporting hospital-wide improvements 
to close the gap in treatment variation. The Toolkit 
recommended key performance indicators (KPIs) for nutrition 
care to enable hospital self-assessment and benchmarking 
to drive up performance. A pilot study to investigate the 
implementation of nutrition care KPIs across Victorian cancer 
treatment settings was commenced in 2016.
Methods
Hospitals were recruited and surveyed to establish pilot KPIs 
and obtain feedback about their involvement. An Excel data 
collection tool was developed and a ‘Nutrition Care Tracker’ 
Dashboard was created to enable visual data display. Decision 
support tools were developed to support consistency in data 
collection methods for benchmarking. The pilot study occurred 
over one week in February 2017 across all pilot sites and 
cancer treatment settings. 
Results
Eleven Victorian Health Services were recruited. The KPIs 
piloted were completion of weight recording and malnutrition 
risk screening on admission. On average, KPI results in the in-
patient setting were below expected targets.  Poorest rates of 
KPI completion exist in ambulatory care settings. Malnutrition 
performance monitoring using the ‘Nutrition Tracker’ and 
decision support tools were highly regarded by participating 
sites and health services are engaged to benchmark quarterly.  
Instant data analysis features were utilised by pilot sites within 
hospital units and governance committees to communicate 
gaps in practice.  
Conclusion
Malnutrition performance benchmarking at a state-wide level 
is feasible and achievable when there are dedicated resources, 
and is needed to drive up current performance.  Further work 
is required to embed malnutrition performance monitoring 
and benchmarking, with a focus on scoping improved nutrition 
care processes in ambulatory settings.  
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345749499
EFFECTS OF SUBSTITUTION OR ADDITION OF CARBOHYDRATE 
AND FAT TO PROTEIN SUPPLEMENTS ON GASTRIC EMPTYING, 
GUT HORMONES AND ENERGY INTAKE IN HEALTHY OLDER 
MEN
Stijn Soenen1, Caroline Giezenaar1, Michael Horowitz1, Ian 
Chapman1
1Discipline of Medicine and National Health and Medical 
Research Council of Australia (NHMRC) Centre of Research 
Excellence (CRE) in Translating Nutritional Science to Good 
Health, The University of Adelaide, Royal Adelaide Hospital, 
Adelaide, South-Australia, Australia
Background: Protein-rich supplements are used widely for 
the management of malnutrition in the elderly. Information 
about the effects of these supplements on energy intake and 
related gastrointestinal mechanisms is limited. The aim of this 
study was to determine the effects of substitution or addition 
of carbohydrate and fat to protein compared to a non-caloric 
control drink on subsequent energy intake, appetite, gastric 
emptying and gut hormones in healthy older men.
Methods: In randomized, double-blind order, 13 healthy 
older men (74±6yrs, 82±3kg, 26±2kg/m2) ingested drinks 
(~450ml) containing: (i) 70g whey-protein (‘protein-280kcal’); 
(ii) 14g protein, 28g carbohydrate, 14g fat (‘mixed-280kcal’), 
(iii) 70g protein, 28g carbohydrate, 14g fat (‘mixed-504kcal’), 
or (iv) an iso-palatable control drink (~0kcal). At regular 
intervals appetite (visual analog scales), gastric emptying 
(3D-ultrasonography), blood glucose and plasma insulin, 
ghrelin, cholecystokinin (CCK) and glucagon-like peptide 1 
(GLP-1) concentrations were measured (0-180min). Ad libitum 
energy intake was quantified from a buffet meal (180-210min).
Results: Appetite and energy intake were not different 
between study conditions (P>0.05). 50% emptying time (T50) 
was slower after protein-280kcal and mixed-504kcal than 
mixed-280kcal and control. Area under the curve (AUC) CCK 
and GLP-1 were higher and ghrelin lower after protein-280kcal 
and mixed-504-kcal than mixed-280kcal and control. Early 
(0-60min) AUC glucose was higher after mixed-280kcal and 
mixed-504-kcal than protein-280kcal and control. Early AUC 
insulin was higher after mixed-280kcal and mixed-504-kcal 
than control, while late (60-180min) AUC was higher after 
protein-280kcal and mixed-504-kcal than mixed-280kcal and 
control.
Conclusions: 280-kcal whey-protein and 504-kcal mixed-
macronutrient drinks had comparably slower gastric emptying 
and more pronounced gut hormone responses than a 280-kcal 
mixed-macronutrient drink and control in healthy older men, 
while appetite and energy intake were comparable after all 
drinks.
345777698
CLINICAL OUTCOMES OF PATIENTS WITH TYPE III INTESTINAL 
FAILURE. A 12 YEAR REVIEW OF A SINGLE CENTRE’S 
EXPERIENCE 
Shanice Sri, Dr. Cherry Koh, Lynn Jones-Hyde, Dr. Sharon Carey
1 University of Notre Dame Sydney, Sydney, Australia
2 SOuRCe (Surgical Outcomes Research Centre), Sydney, 
Australia
3 RPA Department of Intestinal Failure, Sydney, Australia
4 RPA Department of Dietetics, Sydney, Australia
Background: 
Type 3 intestinal failure (IF) requiring home parenteral 
nutrition (HPN) is a rare disease, the small patient numbers has 
flow-on effects in that it translates into small patient numbers 
per centre thereby limiting the experience of each centre. 
The relationship between caseload and patient outcomes is 
well-documented and is likely to apply to IF as IF is a complex 
condition requiring multi-disciplinary input. The purpose of 
this study was to review the experience of Royal Prince Alfred 
Hospital with HPN patients over the past 12 years.
Methods: 
A retrospective review of all HPN patients from 2005-2017 
was undertaken. Medical records were reviewed for patient 
demographics and relevant clinical data including mortality, 
complications and readmissions. Associations were explored 
using chi-square if categorical and t-test if continuous. 
Results: 
There were 40 HPN patients (25 females) with a mean age 
of 53 (+/-14 years) at time of commencement. The average 
duration on HPN at the time of review was 2.5 years (+/- 2.8 
years). Most patients (31, 78%) received HPN 7 days per 
week. Indications for HPN were: short bowel syndrome (20) 
followed by enteric fistula (10), mechanical obstruction (6) and 
intestinal dysmotility (4). All 6 patients with obstruction had an 
advanced intra-abdominal malignancy. 5-year overall survival 
was 41%. Median survival after commencing HPN was 38.4 
months. Cause of death were mostly related to the underlying 
disease or HPN (48% and 26% respectively). The most common 
HPN related complication is line sepsis (24, 60%), which is also 
the most common cause of unplanned readmissions. Patients 
with short bowel or fistula were more likely to develop line 
sepsis (73% vs 20%, p=0.003). Line sepsis is also the most 
common complication complicating any readmission (40 of 152 
readmissions, 26.5%) regardless of indication for readmission.  
Conclusions:
Mortality amongst HPN patients is high. Management of the 
underlying disease and line sepsis are main priorities in these 
patients.
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339010320
HOME ENTERAL NUTRITION SERVICES AT PUBLIC HOSPITALS 
IN NEW SOUTH WALES, AUSTRALIA.
Diana Tang 1, Elizabeth Kumiko Parker 2, Sahrish Sonia 
Faruquie 3, Nadia Hames 2, Peter Talbot 2
1. School of Molecular Bioscience, The University of Sydney, 
NSW 2006, Australia.  
2. Department of Dietetics and Nutrition, Westmead Hospital, 
Sydney, NSW 2145, Australia
3. Department of Diabetes and Endocrinology, Westmead 
Hospital, Sydney, NSW 2145, Australia
Background: There is currently limited information regarding 
the number of patients requiring home enteral nutrition 
(HEN) in NSW.  The lack of a national HEN patient registry 
and overarching national framework for HEN may lead to 
inconsistencies in service delivery and unknown numbers of 
patients requiring HEN.  The aim of this study is to report on 
patient numbers and demographics of the HEN population 
in NSW, and evaluate the implementation of HEN services in 
public hospitals across NSW.
Methods: A cross-sectional study was conducted using two 
online questionnaires, completed by the dietitian mainly 
overseeing HEN at each participating hospital. Data was 
analysed using descriptive statistics, t-tests and Fisher’s exact 
tests. 
Results: Out of the 95 public hospitals identified as having 
a HEN service in NSW, 59 hospitals participated (response 
rate of 62.1%).  Participating hospitals reported a total 
of approximately 7600 HEN patients, 81% requiring oral 
nutrition support and 19% requiring tube feeding. Only 20.3% 
of hospitals reported having a dietitian allocated to HEN, 
and 10.2% of hospitals reported a multi-disciplinary team 
available to manage HEN patients.  Post-discharge follow up, 
as recommended for tube fed and oral patients, was achieved 
by 19% and 25% of hospitals respectively.  An average 
of 54% (range 14-98%) of recommendations on the HEN 
Implementation Checklist were currently in place.  Hospitals 
with a HEN dietitian scored a higher rate of compliance with 
the Implementation Checklist compared with hospitals without 
a HEN dietitian (79.6 ± 15.6 vs 47.6 ± 2.4; P<0.001).            
Conclusion: HEN services at public hospitals across NSW are 
inconsistent, demonstrating inequities in service provision.  
Best practice guidelines are not firmly adhered to, and we 
found that a lack of funding and resource limitations were 
identified as the major barriers to addressing gaps in service 
provision.  
345692665
PLATINUM-INDUCED FATTY ACIDS ARE PRESENT IN CANCER 
PATIENTS BUT MAY NOT BE ASSOCIATED WITH TREATMENT 
RESPONSE
Laisa Teleni[1], Avalyn Stanislaus[2], Rachael Murphy[3], Vijaya 
Damaraju[4], Quincy Chu[2],  Michael Sawyer[2] Barbara van 
der Meij[1,5] Vera Mazurak[2] 
1. Faculty of Health Sciences and Medicine, Bond University, 
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University of Alberta, Canada
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Mater Hospital, Australia
Background: Preclinical studies suggest that hexadeca-
4,7,10,13-tetraenoic [16:4(n-3)], a fatty acid in fish oil, is 
produced in response to platinum-based chemotherapy and 
may induce chemoresistance. This is yet to be confirmed 
in human cancer patients. We aimed to investigate plasma 
16:4(n-3) in non-small cell lung cancer (NSCLC) patients 
undergoing platinum-based chemotherapy with or without 
fish oil supplements and to explore potential relationships 
between 16:4(n-3) and response to treatment.
Methods: Secondary analysis of stored plasma from a RCT of 
NSCLC patients with fish oil (n=11) supplementation versus 
standard care (n=9). Plasma was from pre-chemotherapy with 
follow-up collected at a following chemotherapy cycle. We 
developed and validated a laboratory methodology to measure 
plasma 16:4(n-3) in NSCLC patients.
Results: 16:4 (n-3) was present in patients prior to the start of 
chemotherapy [4.6-93.1nM free 16:4(n-3) and 37.2-567.5nM 
total 16:4(n-3)]. A Mann Whitney U test indicated that the 
median increase in total 16:4(n-3) was greater for the fish oil 
group (median increase = 43.9nM) than standard care (median 
increase = 7.8nM), U = 18, p=0.016, but was no different 
in free 16:4(n-3) between groups (p>0.05). There was no 
significant difference between median total 16:4(n-3) of those 
who responded to treatment [78.8nM (36.1-663.9)] versus 
those who didn’t respond [109.5nM (64.1-476.4)], p>0.05. 
Similarly, there was no significant difference between median 
free 16:4(n-3) of those who responded to treatment [21.9nM 
(3.9-74.7)] versus those who didn’t respond [22.4nM (2.4-
160.1)], p>0.05.
Conclusions:  
The current data show that 16:4(n-3) is detectable in NSCLC 
patients in free and total plasma fractions, even before 
the start of platinum-based chemotherapies, and suggests 
a relationship between fish oil supplementation during 
chemotherapy and plasma 16:4(n-3). There was no significant 
difference in 16:4(n-3) between those who did versus did not 
respond to chemotherapy. This is contrary to the findings 
from pre-clinical studies and suggest that the use of fish 
oil supplements are safe in patients on platinum-based 
chemotherapy.
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DEPRESSED MOOD AND COGNITIVE FUNCTIONS IN PATIENTS 
WITH CANCER ARE ASSOCIATED WITH ALTERATIONS IN 
TRYPTOPHAN METABOLISM
Barbara van der Meij 1, 2, 3, Cindy Lieben 1, Nicolaas Deutz 1, 
Ramon Rodriguez 4,  Fari Koeman 1,  Tiffany Smit 1,  Marielle 
Engelen 1 
1 Center for Translational Research in Aging and Longevity, 
Texas A&M University, College Station, United States
2 Faculty of Health Sciences and Medicine, Bond University, 
God Coast, Australia
3 Nutrition and Dietetics, Mater Group, Brisbane, Australia
4 Division of Hematology/Oncology, Scott and White Memorial 
Hospital, College Station, United States
Background: 
Depression and cognitive deficits have been observed in 
patients with cancer and is thought to be related to the 
degradation of tryptophan (TRP; precursor of serotonin). The 
aim of this study was to investigate the association between 
whole body TRP metabolism and neuropsychological functions 
in advanced cancer.
Methods: 
In 16 patients with solid tumours (C) and 16 age and gender 
matched healthy controls, the rates of appearance (Ra) and 
clearance of TRP were assessed by primed continuous infusion 
of L-[indole-2H5]TRP. Plasma amino acid profile was analyzed 
to measure plasma TRP level, and ratio plasma TRP to Large 
neutral amino acids (LNAA = sum of tyrosine, phenylalanine, 
isoleucine, leucine and valine) calculated as marker of TRP 
uptake into the brain. Mood was assessed by the Hospital 
Anxiety and Depression Score, and cognition by a test battery 
consisting of the Auditory Verbal Learning, Verbal Fluency, 
Trail Making, and Stroop tests. Plasma amino acid levels and 
isotope enrichments were measured by LC-MS/MS. Statistics 
were done by unpaired t-tests, linear regression analyses and 
Pearson’s correlation.
Results: 
Depression scores were higher in C (5.0 vs 2.6, P<0.05), but 
anxiety and cognitive outcomes were comparable between the 
groups. In C, depression categories were  negatively associated 
with plasma TRP (B=-8.3 µmol/L, P<0.01) and positively with 
TRP clearance (B=0.09 L/min, P<0.05). Additionally, we found 
that only in C, TRP Ra was associated with word fluency 
(r=0.70, P<0.01), processing speed (TMT completion time; 
r<-0.54, P<0.05), and verbal learning capacity and memory 
(immediate and delayed recall, learning rate and recognition; 
r≥0.63, P≤0.01). No relationship was found between plasma 
TRP/LNAA ratio and mood or cognition.
Conclusions: 
These findings suggest that an imbalance in TRP metabolism 
plays a role in the
depressive symptoms in patients with cancer and may increase 
their risk of developing cognitive deficits.
345720269
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Jessie Varghese 1, Kym Wittholz 2, Nadia Hendriks 3, Emma 
Bidgood 4, Kate Fetterplace 5. 
1. Department of Clinical Nutrition, Royal Melbourne Hospital, 
Melbourne, Australia 
2.  Department of Clinical Nutrition, Royal Melbourne Hospital, 
Melbourne, Australia 
3.  Department of Nutrition and Dietetics, St Vincent’s Hospital, 
Melbourne, Australia
4.Department of Clinical Nutrition, Royal Melbourne Hospital, 
Melbourne, Australia 
5. Department of Clinical Nutrition, Royal Melbourne Hospital, 
Melbourne, Australia 
Background: Early oral feeding following major gastrointestinal 
(GI) surgery is safe and may improve outcomes, including 
length of stay (LOS) and post-operative complications1. 
Inconsistencies in post-operative diet progression have been 
observed at this Victorian tertiary hospital, despite awareness 
of best practice guidelines. The aim of this audit was to assess 
post-operative diet progression practices and investigate 
the associations with hospital LOS and post-operative 
complications. 
Methods: Prospective observational cohort study of patients 
undergoing major upper and lower GI surgery was conducted, 
over a two month period, at a tertiary hospital in Melbourne. 
Data collection included demographics, daily diet codes, 
nutritional status (subjective global assessment), weight 
change, LOS and post-operative ileus.
Results: Of the 36 patients included, 58% (n=21) were male, 
the mean (SD) age was 56 (16) years, the median (interquartile 
range [IQR]) LOS was 11 [7-17] days and on admission 
21% (n=8) were malnourished. The median [IQR] days to 
commencing any solid diet was 5 [3-7] days. There was a 
strong association between days on a restricted diet (Nil by 
Mouth, Clear Fluids, Fluids Only) and LOS (r=0.54, p=0.001). 
There was a significant difference in the days on a restricted 
diet in those who developed an ileus (mean difference [Md]=6, 
n=10) and those who didn’t ([Md]=3, n=26), (U=44.5, z=-3.05, 
p=0.002). In a subset of patients (n=21), who were weighed 
at discharge, 36% had significant weight loss (>5%) over the 
admission. 
Conclusions: Significant delays in commencing solids were 
observed and the number of days on a restricted diet was 
associated with longer LOS. Patients who developed an ileus 
were on restricted diets for longer. Earlier introduction of 
solids, in line with evidence based guidelines may improve 
patient outcomes1.
References: 1.Weimann A et al.ESPEN guideline:Clinical 
Nutrition in Surgery. Clinical Nutrition 2017;36(3):623-650.
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MULTIDISCIPLINARY EVIDENCE-BASED INTESTINAL 
REHABILITATION: CASE REVIEW OF OPTIMAL OUTCOMES 
DESPITE POOR PROGNOSTIC FACTORS.
Boutaina Zemrani 1, Liz Rogers 1, Helen Shalley 1, Kathleen 
McGrath 1.
1 Royal Children’s Hospital, Melbourne, Australia
Background: 
Short bowel syndrome (SBS) is the most common cause 
of intestinal failure in children. Intestinal rehabilitation 
(IR) is a multimodal patient care model which encourages 
compensatory processes of adaptation in residual bowel 
strongly influencing long-term outcomes.  We report the case 
of a 7-year-old boy with very short SBS who was managed 
using an evidence-based multidisciplinary IR model through a 
challenging clinical course.
Methods: 
The patient was born at 35+2 weeks gestation with antenatally 
diagnosed gastroschisis. He had surgical closure on Day 1 
of life. A laparotomy was performed on Day 12 to resect 
atretic small bowel, leaving 30cm dilated jejunum, jejuno-
colic anastomosis (no ileocaecal valve) and microcolon. Serial 
Transverse Enteroplasty was performed at 2-years-old.
The IR team involved medical, surgical, allied health and 
nursing expertise in a family-centred approach. Management 
strategies included: early enteral nutrition (breast milk), 
optimisation of Parenteral Nutrition (PN), anti-motility agents, 
acid suppression and strict Central Venous Access Device 
(CVAD) management. Complications included multiple septic 
episodes, recurrent small intestinal bacterial overgrowth and 
mild liver fibrosis.
Results: 
The patient was successfully weaned from PN at 3-years-old. 
He is currently 7-years-old, tracking along 50th percentile 
for weight and 75th percentile for height. He enjoys a full 
oral diet with no oral aversion and a good quality of life with 
no developmental concerns. He receives daily anti-motility 
agents, intermittent intramuscular Vitamin B12 and has no 
other micronutrient deficiencies. Periodically, he requires 
supplemental enteral nutrition.
Conclusions: 
We describe successful intestinal adaptation and enteral 
autonomy in a child with very short SBS despite unfavourable 
intestinal prognostic factors and challenging clinical 
circumstances. This case challenges the classically reported 
predictors of intestinal autonomy and highlights the key role 
of evidence-based multidisciplinary IR coordinated care in 
children with SBS. 
42
PBS Information: This product is not available on the PBS
Baxter Healthcare, Old Toongabbie, 2146, NSW, Australia, ANZ/179/17-0005 
Please refer to full product information
before prescribing.AVAILABLE SOON
1800 BAXTER (229 837) or baxterprofessional.com.au
6.3% amino acid with electrolytes, 18.75% glucose with calcium  and 15% lipid
Olimel/PeriOlimel Minimum Product Information
Indication: parenteral nutrition for adults when oral or enteral nutrition is 
impossible, insu	cient or contraindicated. Contraindications: in premature 
neonates, children less than 2 years old; known hypersensitivity to: egg, soya 
or peanut proteins, corn/maize products, components of container, or to any 
of the ingredients; congenital abnormalities of amino acid metabolism; 
severe hyperlipidaemia or severe disorders of lipid metabolism characterised 
by hypertriglyceridaemia; severe hyperglycaemia; unstable conditions (see 
full PI); electrolytes formulatons must not be administered to patients with 
pathologically elevated plasma concentrations of sodium, potassium, 
magnesium, calcium and/or phosphorus; Use with caution in patients with 
severe liver insu	ciency. Precautions: allergic reactions; pulmonary vascular 
emboli and pulmonary distress; precipitate formation; vascular occlusion; 
infectious complications; sepsis complications; Fat Overload Syndrome; 
simultaneously same infusion line with ceftriaxone; refeeding syndrome; 
thrombophlebitis; extravasation; use in patients with: oedema or heart failure, 
metabolic complications, renal insu	ciency. Interactions: no interaction 
studies have been performed with OLIMEL/PERIOLIMEL. Confirm additive 
compatibility and stability of resulting preparation; consider calcium and 
phosphate ratios; do not administer blood simultaneously through same 
infusion tube. Adverse Eects: tachycardia; abdominal pain; diarrhoea; 
nausea; decreased appetite; hypertriglyceridaemia; hypertension; Dosage/-
Method of Use: Dosage needs to be personalised to individual patient need. 
PeriOlimel can be administered through peripheral or central vein. Olimel 
range can only be administered centrally. Refer to full Olimel/PeriOlimel 
Product Information (PI) for more information. Full PI available from Baxter 
Medical Information 1300 302 409 or onecall@baxter.com. v161017
4443
NOTES:
NOTES:
Corporate Communique PTY LTD
ABN: 47120187760
+61 3 5977 0244
   
info@corporatecommunique.com.au
  
Suite J, Building 3, 
Bruce St, Mornington, 
Victoria 3931
AUSTRALIA
www.corporatecommunique.com.au
CORPORATEcommuniqué
eventsoutsidethesquare
Conference organisers:
Evidence-based nutrition for improving patient outcomes
in Clinical Nutrition
